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Plasmodium knowlesi is a simian malaria parasite currently recognized as the fifth 
cause of human malaria. Singapore reported its first local human knowlesi infection in 
2007 and epidemiological investigations revealed that long-tailed macaques were the 
reservoir host of this blood parasite. Apart from P. knowlesi, long-tailed macaques are 
also natural host to P. coatneyi, P. fieldi, P. cynomolgi and P. inui, of which the latter 
two were also found to be infectious to humans under laboratory conditions. As there 
was no previous study of simian malaria parasites in Singapore’s macaques, this study 
aims to determine their prevalence for the risk assessment of zoonotic transmission of 
simian malaria parasites to the general human population. Detection and accurate 
identification of simian malaria parasites through microscopy is typically challenged 
by low parasitemia, mixed species infection in the natural hosts and overlapping 
morphological characteristics among the different simian Plasmodium species. A 
sensitive Plasmodium parasite screening polymerase chain reaction (PCR) assay and a 
simian malaria species-specific nested PCR assay were thus developed. The PCR 
primers for Plasmodium parasites screening were designed against the conserved 
regions in the small subunit ribosomal RNA (SSU rRNA) genes. These primers were 
able to detect the four human and five simian Plasmodium species parasites, and 
could be used in both conventional and real-time PCR. The simian Plasmodium 
species-specific nested PCR assay, on the other hand, was developed using the 
Plasmodium circumsporozoite protein (csp) gene. Plasmodium screening on 65 peri-
domestic and 92 wild macaques revealed that the former group was uninfected, while 
71.7% of the sampled wild macaques were infected. Peri-domestic macaques were 
found in areas near human habitations while wild macaques were caught in military 
vii 
 
forest where access is restricted to the general public. All five simian Plasmodium 
species were detected, with P. knowlesi having the highest prevalence (68.2%), 
followed by P. cynomolgi (60.6%), P. fieldi (16.7%), P. coatneyi (3.0%) and P. inui 
(1.5%). Co-infection with multiple species of Plasmodium parasites was also 
observed; double infection was detected in 23 (34.8%) macaques while five (7.6%) 
were infected with three Plasmodium species. Phylogenetic analysis of the non-repeat 
region of the Plasmodium csp gene from 15 infected macaques revealed high 
genotypic diversity of the parasites, reflecting a high intensity of malaria transmission 
among the macaques in the forest. On the other hand, all four local knowlesi cases 
had single P. knowlesi genotype which was identical to the P. knowlesi isolates of 
some macaques, suggesting that macaques were the reservoir hosts of the knowlesi 
malaria. Identical Plasmodium csp sequences shared by macaques caught at different 
timepoint also illustrates an ongoing sylvatic transmission. Despite these findings, the 
risk of zoonotic transmission of simian malaria parasites to the general population is 
assessed to be low as malaria parasites were absent among peri-domestic macaques, 
and all human knowlesi cases reported in Singapore were thus far occupational or 
travel related. However, to enable continuous risk assessment and surveillance, more 
studies will be required to determine the identity and distribution of the mosquito 
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1.1  Malaria 
Malaria is an ancient disease, first described by ancient Egyptians in 1500B.C [1]. 
Despite years of intensive research, no successful vaccine for this disease has yet been 
developed, and it remains a serious public health problem in many tropical countries. 
According to World Health Organization (WHO), 225 million cases of malaria were 
reported in 2009, with a mortality of 781,000 [2]. In 2009, an estimated 1.3 billion 
people or 76% of the total population in Southeast Asian region were at risk of 
malaria [3].  
 
Malaria is caused by protozoan parasites of the genus Plasmodium, family 
Plasmodiidae, suborder Haemosporidiidae, order Coccidia. Approximately 170 
species of Plasmodium parasites, capable of infecting rodents, primates, reptiles and 
birds, have been discovered thus far [1, 4]. Five species of parasites, namely P. 
falciparium, P. vivax, P. ovale, P. malariae and P. knowlesi have been reported to 
cause disease in humans. Plasmodium vivax is the most widely distributed human 
malaria, while infection by P. falciparium is usually the most fatal. Plasmodium 
knowlesi, a simian malaria parasite originating from the Old World macaques, was 




   











The classic clinical symptoms of malaria infection include intermittent fever, 
shivering, joint pains, headaches and repeated vomiting. If treatment is delayed, it can 
lead to severe complications such as renal failure, hypoglycemia, anemia, pulmonary 
edema, shock and coma, and eventually death [6]. 
 
1.1.1 Life cycle of malaria parasites 
All malaria parasites require two hosts to complete their life cycle; the definitive 
invertebrate hosts and the intermediate vertebrate hosts. Most Plasmodium parasites 
are transmitted by mosquitoes, and those infecting human and non-human primates 
are transmitted exclusively by anopheline mosquitoes [4, 7].  
 
Vertebrate hosts are infected through the bite of an infective mosquito when 
sporozoites are inoculated into the bloodstream during feeding (Figure 1.2). These 
sporozoites migrate to the liver and invade the hepatocytes, where they undergo an 
extensive replication known as primary schizogony, to produce exoerythrocytic 
schizonts (exoerythrocytic phase). Some species of Plasmodium parasites, such as P. 
vivax, P. ovale, P. cynomolgi, P.fieldi and P. simiovale, can produce a latent hepatic 
stage known as hypnozoites, which lay dormant in the liver for a period of time before 
invading the blood cells again [4, 7-10]. 
 
Each exoerythrocytic schizonts may contain 30,000 to 50,000 merozoites, which are 
released into the bloodstream where they invade the red blood cells (erythrocytic 

















ring forms or early trophozoites, which will develop into mature trophozoites. These 
trophozoites then undergo schizogony, producing schizonts. The infected erythrocytes 
eventually lyze and merozoites are released into the blood stream. Some merozoites 
invade other erythrocytes and reinitiate another asexual erythrocytic cycle, while 
others differentiate into the microgametocytes (male) and macrogametocytes 
(female). The release of cellular contents from the ruptured erythrocytes triggers the 
host’s immune system, resulting in clinical symptoms of fever and chills. Depending 
on the species of malaria parasite, the periodicity (time required to complete an 
erythrocytic cycle) ranges from 24 hours (quotidian periodicity) to 48 hours (tertian 
periodicity) or 72 hours (quartan periodicity) [7, 9]. 
 
The infection cycle in invertebrate hosts begins when it ingests both gametocyctes 
during its blood meal. The fall in temperature and presence of xanthurenic acid in the 
mosquito’s gut trigger the development of the gametocytes to gametes. In the 
mosquito’s midgut, the microgametes fuse with the macrogametes to form a zygote. 
Within 24 hours, the zygote differentiates into a motile and elongated ookinete, which 
then penetrates through the midgut epithelium and develops into an oocyst. Oocysts 
undergo sporogony (asexual multiplication in mosquito) and produce thousands of 
sporozoites. Eventually, the oocysts rupture, releasing the sporozoites which enter the 
haemolymph and subsequently migrate to the salivary gland. Inoculation of the 
sporozoites during blood feeding into a new vertebrate host perpetuates the malaria 





1.2 Non-human primate malarias 
More than 20 species of simian malarial parasites that infect monkeys, apes and 
lemurs have been described (Table 1.1) [1, 7, 12]. These parasites, together with their 
natural hosts, can be found in the Asian, African, Central and South American region. 
Most of these parasites can be grouped with the four human malaria parasites based 
on the similarity of their erythrocytic cycle periodicity and morphology [7]. The 
distribution of simian malaria parasites affecting macaques in Southeast Asia was 
reported to follow the distribution of the Anopheles leucosphyrus group of mosquitoes 
(Figure 1.3) [12]. 
 
1.3 Simian malaria infections in man 
Several studies had been conducted to test the infectivity of simian malaria parasites 
in man. The first experiment was carried out by Blacklock and Adler in 1922, using P. 
reichenowi, the simian form of P. falciparium [13]. However, the transfer of this 
simian malaria parasite species from chimpanzee to human volunteer using blood 
passage failed. The first reported successful experimental transmission was performed 
a decade later by Knowles and Das Gupta, who transmitted P. knowlesi to three 
human volunteers using blood inoculation [14]. The clinical symptoms observed 
ranged from mild, intermittent to severe fever. Unlike other human malaria infections, 
the fever of this simian malaria infection was observed to be of a daily remittent type. 
With the knowledge of P. knowlesi capable of inducing fever, this parasite was later 
used as a pyretic agent to treat patients with neuro-syphilis [15]. Other than P. 
knowlesi, the same author also successfully infected human volunteers with P. inui 
using blood passages in 1938 [16].  
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Table 1.1: List of non-human primate Plasmodium species, their periodicity, 
distribution and natural hosts [1, 7, 9, 12, 17]  
Plasmodium 
species 
























Southeast Asia, India, Sri Lanka 
Southeast Asia 
Southeast Asia 
Southeast Asia, India, Sri Lanka, Taiwan 
India, Sri Lanka 
Sri Lanka 





































































“*”, “**’, “***”, “****” indicates malaria parasites grouped under the falciparum-, 









Figure 1.3: Distribution of simian malaria parasites in macaques [7, 12, 18-28] and the 











On the other hand, attempts to infect human with simian malaria parasites through 
mosquitoes were not successful [30, 31]. Hence, there was a general consensus that 
transmission of simian malaria parasites to humans was not possible. As such, non-
human primate malaria was not taken into consideration during the strategic planning 
of malaria eradication during the World Health Assembly in 1955 [32]. In 1960, this 
dogma was proven wrong when reports of accidental human infection of P. cynomolgi 
by An. freeborni surfaced in two separate laboratories in the United States [33, 34]. 
These sparked the re-initiation of experimental mosquito transmission of simian 
malaria to man, and revealed the transmissibility of P. knowlesi, P. inui and P. 
cynomolgi from monkey to man, and from man to man through infectious mosquito 
bites under laboratory setting [35-39]. Likewise, other simian malaria parasites 
originating from apes and New World monkeys (P. schwetzi, P. brasilianum, P. 
simium and P. eylesi) were also proven to be transmissible to man [38, 40-42].  
 
Substantial proof of natural infection of simian malaria parasites in man was only 
demonstrated in 1965 when Chin and co-workers reported a natural P. knowlesi 
infection in an American man who had spent nights working in a jungle in Pahang, 
peninsular Malaysia [43]. Surveillance studies in that locality revealed the presence of 
P. knowlesi in a sample of the wild macaque population there. However, when blood 
samples from residents in the area were pooled and injected into rhesus monkeys, a 
monkey species that typically does not survive P. knowlesi infections, none of these 
rhesus monkeys were infected.  This large scale surveillance study concluded that 
human P. knowlesi infection was extremely rare. A few years later in 1971, another 
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presumptive case of natural human P. knowlesi infection was also reported in Johore, 
peninsular Malaysia [44]. 
 
The belief of human P. knowlesi infection being a rare incidence was overturned in 
2004 when a large focus of human knowlesi infection was detected in the Kapit 
division of Sarawak, East Malaysia [45]. These cases were initially misdiagnosed as 
P. malariae using microscopy, although the symptoms were atypical of P. malariae 
infection and nested PCR failed to detect its DNA. Using molecular methods, 106 
(51%) malaria cases in Kapit were attributable solely to P. knowlesi infection and 14 
(7%) were co-infections of P. knowlesi and other human Plasmodium species. In 
contrast to the rare and sporadic reports of human P. knowlesi infection in the 1960s, 
this is the first report of a large focus of naturally acquired simian malaria infection in 
man. As P. knowlesi is morphologically similar to P. falciparum and P. malariae 
during the early ring stages and late trophozoites respectively, it is not possible to 
identify P. knowlesi parasites using microscopic observation of the thin blood film. 
Hence, Singh and co-workers designed a nested PCR assay for detection of P. 
knowlesi [45]. With the diagnostic test made available and an increased awareness of 
P. knowlesi as a possible cause of malaria in human, reports of naturally acquired 
human knowlesi cases surfaced in other parts of Southeast Asia: peninsular Malaysia 
[24], Singapore [46], Indonesian Borneo [47, 48], Sabah [49], Philippines [50], 
Thailand [51-53], Myanmar [54, 55], Vietnam [56, 57] and Cambodia[58]. The 
impact of  P. knowlesi on travel medicine has also been recognised as non-endemic 
regions of the world, such as Europe [59-61],  New Zealand[62],  Australia [47] and 
the United States [63], reported importation of P. knowlesi cases from the Southeast 
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Asia region. Most significantly, fatalities due to P. knowlesi infections have been 
reported [64, 65]. The increased incidence of P. knowlesi infection and its associated 
fatalities prompted a synchronous echo from the public health community to relook 
into the impact of knowlesi malaria, and a classification of P. knowlesi as the fifth 
human malaria parasite [66-70]. However, unlike the other four human malaria 
parasite, P. knowlesi infection remains a zoonotic disease as there has been no 
evidence to suggest the occurrence of human-to-human transmission [25].  
 
1.4  Detection and identification of simian malaria parasites 
1.4.1 Microscopic observations 
Microscopic examination of the Giemsa stained thin blood film is a universally 
accepted gold standard for primary identification of malaria parasites. It is also the 
main method for identification of Plasmodium parasites in non-human primates since 
the early 1900s [7, 9, 12, 18, 22, 23, 28, 71, 72]. However, there is an inherent 
difficulty in the accurate identification of simian malaria parasites due to overlapping 
morphological characteristics among these parasites [1]. Besides, individual macaques 
are often co-infected with two or more species of malaria parasites; and coupled with 
a low parasitaemia, microscopic identification of simian malaria parasites became 
confusing, inaccurate and insensitive [1, 7].   
 
There are also shared morphological characteristics between simian malaria parasites 
and human malaria parasites. As a result, a significant proportion of the P. knowlesi 
cases in Kapit, Sarawak, were previously misdiagnosed as P. falciparum or P. 
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malariae using microscopy [45]. In addition, the morphology of P. cynomolgi and P. 
fieldi resembles that of P. vivax and P. ovale, respectively [27, 33], , and P. inui is 
reminiscent of P. malariae [7]. Hence, the accuracy of the identification using 
microscopy is greatly dependent on the experience of the microscopists.   
 
 1.4.2 Polymerase Chain Reaction (PCR) assays 
Although microscopic examination of blood film remains the gold standard for 
malaria diagnostics, there is an increasing trend in using PCR to confirm the presence 
of malaria infection. As PCR can provide discriminatory power that could circumvent 
the limitations of identifying malaria parasites using microscopy, this method is 
frequently used when epidemiological and clinical findings do not match the 
microscopy results.  
 
The nested PCR assay is a widely used method to detect the four human malaria 
parasites [73]. The nest one amplification reaction uses the Plasmodium genus- 
specific PCR primers, which amplifies all Plasmodium species’ small subunit 
ribosomal RNA (SSU rRNA) gene. To determine the species of Plasmodium parasites 
present, the products of this nest one PCR reaction are subjected to four separate nest 
two amplification reactions, using primers specific for each human malaria parasite 
species. This assay is reported to have higher sensitivity than the conventional 




The high sensitivity of the malaria-specific nested PCR assay allows the detection of 
malaria sporozoites in mosquitoes [75-77], and dried blood spots on filter papers [74, 
78], making it useful for epidemiological investigation of malaria outbreaks and the 
detection of low-grade parasitaemia in high malaria endemicity areas [79]. This 
method has also been verified by the US CDC researchers to be the method of choice 
for detection of mixed malaria infections and sub-clinical infections [80]. 
 
Due to similarities in morphology between simian malaria parasites and that of 
humans, it is difficult to ascertain the occurrence of zoonosis through microscopy. 
Hence, cases of naturally-acquired human infection of simian malaria parasite may be 
overlooked. Nested PCR using P. knowlesi-specific primers played an important role 
in the discovery of a large focus of human knowlesi malaria, previously diagnosed as 
either P. malariae and/or P. falciparum cases. In the 1940s, Field illustrated an 
infection which he considered as an aberrant form of P. vivax in two patients from 
Malaysia [81]. Twenty years later, Sandosham et al. presented a slide of P. cynomolgi 
bastianellii, which had identical features to what Field had described [27]. Due to the 
close morphological similarity between these parasites, P.cynomolgi could be 
transmitted unknowingly to humans in nature. The development of simian malaria 








1.5  Malaria in Singapore 
1.5.1 The historical perspective 
Singapore attained the malaria-free status from World Health Organization (WHO) on 
22 Nov 1982. However, the route to attaining the stature of malaria eradication is not 
without its labours. Singapore, like its neighbouring countries in Southeast Asia, was 
also once plagued with malaria.  
 
Malaria was rampant in the early British colonial ruling days. In 1908, it was the 
second leading cause of death after tuberculosis. At the peak of an outbreak in 1911, 
about 20 deaths due to malaria were reported in a day. Hence, to bring the malaria 
epidemics under control, a comprehensive anti-malaria drainage system and oiling 
programme was introduced [82]. In 1966, malaria became a notifiable disease and all 
notified cases were investigated for epidemiological and entomological information. 
Legislation  to control the breeding of Anopheles vectors was also tightened in 1968 
[83]. 
 
However, rapid urbanization in the 1970s exacerbated the malaria problem in 
Singapore as land developments created favourable breeding grounds for the 
Anopheles vectors, and construction workers were mostly recruited from malaria-
endemic countries. Despite precautionary measures to prevent Anopheles breeding 
and efforts to screen foreign workers for malaria parasites, malaria outbreaks still 
occurred. A revolutionary change in the strategy of malaria control in Singapore took 
place in 1975 when more aggressive efforts were taken to break the transmission 
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cycle. Vector surveillance and control was stepped up and maps of malaria sensitive 
areas were updated bi-yearly. Oiling programme was also extended to previously 
uncontrolled areas and areas with vector breeding were oiled frequently. Foreign 
workers’ dormitories were also routinely sprayed with insecticide. This highly 
structured vector surveillance and control program nearly eradicated the malaria 
vectors. Whenever a malaria transmission is suspected, active case detection and mass 
blood surveys ensued until the reservoir of infection has been detected and treated. 
Vector control efforts such as larvicidal measures and residual spraying were also 
intensified. With this control strategy, the number of local malaria cases began to 
decline [83] (refer to Figure 1.4). 
 
1.5.2 The current situation 
Since attaining the malaria-free status, Singapore has maintained the standing for 
years without major local transmissions. Although malaria cases have been reported, 
more than 90% of these cases were contracted in Southeast Asia and the Indian 
subcontinent as most Singaporeans travelled to malaria endemic countries without 
taking adequate personal precautionary measures and chemoprophylaxis. Apart from 
local residents, work permit holders, student pass holders, foreigners seeking medical 
treatment in Singapore and tourists made up the rest of the overseas-acquired malaria 






Figure 1.4: Malaria trend in Singapore, 1963 – 1982 [83]. The inception of new 
control strategy in 1975 reduced the number of local cases significantly. 
 
 
Figure 1.5: Malaria trend in Singapore, 1982-2006 [84]. Most cases were imported 






With the influx of foreign labor from neighboring malaria-endemic countries and 
presence of pockets of Anopheles vectors, Singapore has not been spared from the 
occasional localised outbreaks of malaria. Between 1983 and 2009, 30 localised 
outbreaks involving a total of 220 cases were reported. These outbreaks include those 
that occurred in Punggol point, Tanjong Rhu/ East Coast Park, Dairy Farm, Mandai-
Sungei Kadut, Jurong Island, Sembawang and Lim Chu Kang [84, 85]. All were 
eliminated through intensive epidemiological surveillance and vector control 
operations. 
 
Apart from human malaria transmission, malaria parasites from the monkey reservoir 
too pose a threat to Singapore’s malaria-free status. Singapore reported its first 
naturally-acquired human knowlesi malaria in 2007 [46]. The index case was a soldier 
who contracted P. knowlesi infection after a period of training in a forested area 
inhabited by the long-tailed macaque (Macaca fascicularis) in Lim Chu Kang, north-
western Singapore. This prompted a fever monitoring and surveillance for soldiers 
who had visited the affected forest, which detected an additional five cases - four 
cases in 2007 and one in 2008 [20, 86]. All were military personnel who had no travel 
history, but had visited this restricted access forest prior to the onset of symptoms 
[20]. 
 
As long-tailed macaque, the natural host of P. knowlesi, is an inhabitant in this 
affected forest and various public nature parks, a joint operation was carried out by 
the Singapore Armed Forces, the National Parks Board and the National Environment 
Agency (NEA) to evaluate the risk of P. knowlesi infection in Singapore. Three long-
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tailed macaques were sampled from the heart of the restricted-access forest and ten 
were sampled from a public nature reserve park. All three macaques from the 
restricted forest were infected with P. knowlesi while those from the nature reserve 
park were free from malaria infection. Phylogenetic analysis of the non-repeat region 
of the P. knowlesi circumsporozoite protein gene revealed shared genotypes between 
the human cases and the infected macaques, indicating that the cases had acquired the 
infection in the vicinity where these monkeys were found [20].  
 
The finding of P. knowlesi in Singapore is of no surprise as this parasite was first 
discovered in India in 1931, from a long-tailed macaque imported from Singapore 
[14, 87]. The re-discovery of P. knowlesi parasites from long-tailed macaques 80 
years later demonstrated the continuous and ongoing sylvatic transmission of P. 
knowlesi among the local long-tailed macaque population. The long-tailed macaque is 
the most predominant non-human primate in Singapore. Apart from P. knowlesi, this 
species of macaques is also known to harbor P. cynomolgi, P. inui, P. fieldi and P. 
coatneyi [7]. However to-date, there has been no reports on the prevalence of malaria 
in Singapore’s macaques. Surveillance studies of natural incidence of simian malaria 
parasites in wild macaques had been conducted in Malaysia, Thailand, Indonesia, 
Cambodia, Philippines, Taiwan, Pakistan and Bangladesh [12, 23, 24, 28].  
 
Detection and identification of simian malaria parasites by microscopic observation of 
the thin blood film has been stricken with difficulties and limitations, as previously 
described. Correct identification can be achieved with PCR assays using primers 
specific for each simian malaria parasite. These assays will also be useful in detecting 
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zoonoses in humans, which may be overlooked using microscopy, due to close 
morphology between simian and human malaria parasites.  
 
1.6 Objectives of the study 
The report of the locally-acquired knowlesi cases and the subsequent detection of P. 
knowlesi parasites in a sample of local wild macaques demonstrate a potential risk of 
zoonotic transmission of P. knowlesi in Singapore. However, as only a small sample 
of macaques was tested for P. knowlesi previously, there is a need to screen for simian 
malaria parasites in a larger population of macaques, preferably from different 
geographical locations, for a better understanding on the prevalence rate of malaria 
infection in local macaques. This is to enable a risk evaluation of zoonotic 
transmission of simian malaria parasites to the general human population.  
The overall objective of this project is to identify the simian malaria parasites in 
Singapore’s long-tailed macaques. Specifically, the study aims to: 
1. Develop a simian malaria species-specific PCR assay to identify P. knowlesi, 
P. cynomolgi, P. inui, P. fieldi and P. coatneyi infections in long-tailed 
macaques,  
2. Determine the prevalence of simian malaria parasites in Singapore’s long-
tailed macaque population,  
3. Characterize the circumsporozoite protein (csp) genes of simian malaria 
parasites found in long-tailed macaques, and 
4. Determine the molecular epidemiological linkage between the P. knowlesi 
isolated from Singapore’s human cases and those isolated from local long-
tailed macaques.  
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The information gathered from this study will not only constitue the first report of the 
prevalence of malaria infection in Singapore’s macaques, but also help in expanding 




















Development of PCR assays for screening of simian malaria parasites  
2.1 Introduction 
Polymerase chain reaction assays are often used in malaria surveillance studies due to 
its ability to process large sample numbers and its higher sensitivity as compared to 
the microscopic examination of blood smears [74]. Although microscopy has been the 
gold standard for malaria diagnosis, it is time consuming to screen large number of 
samples using this method due to the preparation and interpretation of individual 
slides [88]. In addition, false negative results may occur while screening samples with 
low parasitemia [79, 89].  In view of this, a Plasmodium genus-specific nested PCR 
assay was developed by Singh and co-workers [74].  However, due to the need to 
perform two separate PCR reactions to confirm malaria infection, this assay can be 
time consuming, expensive and prone to PCR product carry-over contamination. To 
overcome this limitation, a sensitive Plasmodium genus-specific PCR assay 
(conventional and real-time format) using a single pair of primer was developed in 
this study.  
 
A simian malaria species-specific PCR assay will also be developed for the 
identification of the five simian malaria parasites (P. knowlesi, P. cynomolgi, P. inui, 
P. fieldi and P. coatneyi) which long-tailed macaques are natural host to. As these five 
parasites have overlapping morphological characteristics at different life stages, their 
identification and differentiation using microscopy is impossible.  On top of surveying 
simian malaria parasites in monkeys, this assay can also be used in the confirmation 
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of P. knowlesi infection in humans. The published P. knowlesi- specific PCR primers 
(Pmk8 and Pmkr9), was recently reported to exhibit stochastic cross amplification 
with P. vivax genomic DNA [90], resulting in misidentification of these two parasites 
in patients. Hence, the development of the simian malaria species-specific PCR assay 
will be useful in the differentiation of P. knowlesi and P. vivax infections in humans.   
 
Apart from P. knowlesi, other simian malaria parasites, such as P. cynomolgi and P. 
inui, were also shown to be potentially infectious to humans [16, 33, 36, 37, 39, 91, 
92]. The design of a simian malaria species-specific PCR assay will therefore be 
useful in the surveillance of these parasites in macaques for the risk assessment of 
potential zoonotic transmission of simian malaria parasites to the general human 
population. Moreover, it could also aid in the detection of naturally-acquired P. 












2.2 Materials and methods 
2.2.1 Source of Plasmodium DNA material for PCR assays development  
Filter paper blood spots of P. malariae and P. ovale were acquired from the National 
Malaria Reference Centre, which was based in the Department of Microbiology, 
National University of Singapore prior to 2009. This centre is currently managed by 
the National Public Health Laboratory, Ministry of Health, Singapore. Plasmodium 
falciparum, P. vivax and P. knowlesi were obtained through the routine malaria 
diagnostic blood samples received by the Environmental Health Institute (EHI). 
Bioethics approval and informed consent from patients had been obtained for the use 
of these samples. Blood spots containing P. coatneyi, P. cynomolgi, P. fieldi and P. 
inui on the Isocode™ Stix (Krackeler Scientific, Inc., Albany, N.Y.) were obtained 
from the Laboratory Research and Development Unit (LRDU) of the Malaria branch, 
Division of Parasitic Diseases and Malaria, Centers for Disease Control & Prevention 
(CDC), Georgia, USA (Appendix A).  
 
2.2.2 DNA extraction  
2.2.2.1 Filter paper blood spots 
DNA was extracted from dried filter paper blood spots using InstageneTM (Bio-Rad 
Laboratories, Hercules CA, USA) based on the method described by Cox-Singh et al. 
[78]. Two hundred microlitres of fully suspended InstageneTM matrix was added to a 
clean 1.5ml microcentrifuge tube using a large bore pipette tip. Two dried blood spots 
were clipped out using an ethanol flamed paper punch. The clippings were then added 
into the InstageneTM suspension. The tube was incubated at 56°C for 30min, with 
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vortexing for 10sec every 15min of incubation, before it was placed in a boiling water 
bath for 8min. It was then centrifuged at 12,000 rpm for 3min and the supernatant 
(containing the DNA) was decanted. The DNA template was stored at - 20°C until 
further use. 
2.2.2.2  Blood spots on Isocode™ Stix 
Extraction of DNA from blood spotted on Isocode™ Stix was carried out using 
protocol published by CDC’s Division of Parasitic Diseases and Malaria [93]. One 
triangle of the dipstick was clipped off and transferred into a microcentrifuge tube and 
washed twice with 500µl of deionized sterile water (dH2O) by vortexing three times 
for at least 5sec. After complete removal of dH2O, the tube was briefly centrifuged 
and the residual water was pipetted off. Fifty microlitres of dH2O were added and 
incubated at 95°C for 30min. Finally, the tube was gently tapped 20 times before the 
supernatant was transferred into a new microcentrifuge tube. The DNA template was 
then stored at - 20°C until further use. 
2.2.2.3  Whole blood 
DNA was extracted from 200 µl of whole blood (venous blood in EDTA anti-
coagulant) using DNeasy® Blood and Tissue kit (QIAGEN, Hilden, Germany) 
according to the manufacturer’s instructions. Briefly, 20 µl of Proteinase K was added 
into a 1.5ml microcentrifuge tube, followed by 200µl of the sample whole blood and 
200µl of Buffer AL. The sample was vortexed before incubating at 56°C for 10min. 
Two hundred microlitres of molecular grade absolute ethanol was then added to the 
sample followed by vortexing. The entire mixture was pipetted into the DNeasy Mini 
spin column placed in collection tube. The column was centrifuged at 8,000rpm for a 
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minute. The flow-through and the collection tube were discarded. Five hundred 
microlitres of wash buffer AW1 was then added to the spin column coupled with a 
new collection tube, followed by centrifugation at 8,000rpm for a minute. The flow-
through and collection tube were discarded and 500µl of the final wash buffer AW2 
was added into the column, with a new collection tube. Final centrifugation at 
14,000rpm at three minutes was applied to dry the membrane of the spin column. To 
elute the DNA, the column was transferred to a sterile 1.5ml microcentrifuge tube and 
200µl of buffer AE was added directly onto the column membrane. The column was 
incubated at room temperature for a minute and finally spun at 8,000rpm for a minute 
to elute.  
2.2.3 Development of Plasmodium genus-specific PCR assays 
2.2.3.1 Design of Plasmodium genus-specific PCR primers 
Sequences of the small subunit ribosomal RNA (SSU rRNA) genes of both sexual and 
asexual stages of human and simian Plasmodium species were retrieved from 
GenBank database. These sequences were aligned using the MegAlign software 
(DNASTAR, Lasergene, USA) and the Plasmodium genus-specific primers were 
designed based on the conserved regions of the gene. Figure 2.1 illustrates the 
alignment of the reference sequences and the selection of potential primer binding 
sites. All oligonucleotides (top-purified grade) were synthesized by a company 
specialized in oligonucleotide synthesis (AITbiotech Pte Ltd., Singapore). The 
oligonucleotide sequences are shown in Table 2.1. The theoretical melting 
temperature (Tm) for each primer was calculated using the basic Wallace rule [94]:    





Figure 2.1: Alignment of SSU rRNA genes of the different Plasmodium species for 
design of the Plasmodium genus-specific primers. 
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2.2.3.2 Use of primers PlasF and PlasR for conventional PCR 
To determine the optimum annealing temperature required for primers PlasF and 
PlasR, amplification was performed in a 50µl -reaction mixture (as illustrated in Table 
2.2), using gradient conventional PCR (Veriti® Thermal Cycler, Applied Biostsyems, 
Foster City, CA USA). The temperature tested was between 51oC to 61oC, with an 
increment of 2oC between each test temperature. The DNA templates used for testing 
were genomic DNA of P. vivax, with parasite count of 100, 0.3 and 0.06 parasite/µl. 
Separate reactions with genomic DNA of uninfected human and macaque samples 
were also included in the PCR optimization process. This was to test for any cross-
reactivity of the primers with these DNA.  The PCR parameters are listed in Table 
2.3. 
  
2.2.3.3 Comparison of sensitivity of detection with nested PCR assay 
To determine and compare the sensitivity of the PCR assay, blood from P. vivax 
infected patient was used. The parasite density of this sample was determined by 
counting the number of parasites per 200 leukocytes. The parasite density was 
converted into parasites/µl, assuming a mean leukocyte count of 8000 [95]. 
Thereafter, the blood sample was diluted with malaria-free blood to obtain a 
theoretical parasite density of 100, 50, 25, 12.5, 6.25, 3.13, 1.56, 0.78, 0.39, 0.195, 
0.0975, 0.0488, 0.024, 0.012, 0.006 and 0.003 parasites/µl of blood. The DNA of 
these serially diluted P. vivax blood samples were extracted according to the protocol 
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mentioned in Section 2.2.2.3, and tested with the primers PlasF and PlasR using the 
optimized annealing temperature.  







RNase & DNase-free molecular grade water  
(Promega, Madison WI, USA) 
- 18.75 
5x reaction buffer, green (Promega) 1x 10.0 
MgCl2 25mM (Promega) 2.5 mM 5.0 
dNTP mix, 10mM each  (Promega) 200 µM each 1.0 
Forward primer (2.5 µM) 0.25 µM 5.0 
Reverse primer (2.5 µM) 0.25 µM 5.0 
GoTaq DNA polymerase, 5U/ µl (Promega) 1.25 U 0.25 
DNA template  - 5.0 




Table 2.3: Cycling parameters for conventional PCR optimization 
Steps Temperature/oC Time/s No. cycles 
Initial denaturation 95 240 1 
Denaturation 95 30 
44 Annealing X 30 
Extension 72 30 
Final extension 72 120 1 
 




To compare the sensitivity of the optimized single round PCR assay with that of the 
published Plasmodium genus-specific nested PCR assay, the same panel of DNA was 
amplified using primers rPLU1 and rPLU5 followed by rPLU3 and rPLU4 as 
described by Singh et al. [74]. The PCR products were analyzed by electrophoresis in 
2% agarose gel (1st Base Pte Ltd, Singapore), stained with Gel-RedTM (Biotium, 
Hayward, CA, USA), and observed under ultraviolet transillumination.  
 
2.2.3.4 Use of primers PlasF and PlasR in real-time PCR assay  
Real-time PCR using SYBR green method was carried out using LightCycler® 480 
Instrument (Roche Diagnostics, Penzberg, Germany). The components of the real-
time PCR mix and cycling parameters for the PCR program are listed in Table 2.4 and 
2.5, respectively.  
After PCR amplification, Tm curve analysis and melting temperature was performed 
using the LightCycler® 480 Melting Curve analysis software. The PCR products were 
heated to 95oC for 30sec and cooled to 60oC for 30 sec and then slowly heated back to 
95oC at a rate of 2.2oC/sec.  Obtained fluorescence signals are continuously monitored 
during the slow heating process.  Plotting the fluorescence (F) versus temperature (T) 
generates the melting curve chart.  Melting temperature was determined using the 
LightCycler® 480 Basic Software Tm calling analysis module by plotting a derivative 
melting curve (-dF/dT) where the center of a melting peak corresponds to the point of 
inflection. Amplification graphs were checked for the cross-point (Cp) value of the 
PCR product. The Cp value represented the cycle by which the fluorescence of a 




Table 2.4: Components of “master-mix” for real-time PCR assay 
Components 
 
Final concentration Volume 
(µl) 
RNase & DNase-free molecular grade water  
(QIAGEN, Hilden, Germany) 
- 3 
2x Quantitect SYBR Green PCR Master Mix 
(QIAGEN) 
1x 10.0 
PlasF (10 µM) 0.50 µM 1.0 
PlasR (10 µM) 0.50 µM 1.0 
DNA template  - 5.0 














Denaturation 95 900 1 4.4 None 
Amplification 94 15  
50 
2.2 None 
 50 30 2.2 None 
 72 30 4.4 Single 
Melting 95 30  
1 
4.4 None 
 60 30 4.4 None 
 95 0 2.2 Continuous 





2.2.3.5 Sensitivity and specificity of real-time PCR assay using primers PlasF and 
PlasR 
The sensitivity of the primers PlasF and PlasR in real time PCR assay was determined 
based on both parasite density (Section 2.2.3.3) and parasite’s SSU rRNA copy 
numbers (Section 2.2.3.6.5). 
The specificity of the real-time PCR assay in detecting Plasmodium parasites was 
determined by comparing the amplification results obtained using the DNA of four 
human and five simian malaria parasites, with that of DNA from the non-infected 
human and macaque samples.   
 
2.2.3.6 Preparation of plasmid standards for quantitative real-time PCR assay 
2.2.3.6.1 Amplification of gene insert for plasmid standards 
The gene insert for the control plasmid was a segment of the SSU rRNA gene, which 
encompassed the region amplified by the designed primers PlasF and PlasR. The 
primers used in the amplification of this gene insert are given in Table 2.6. Using 
protocol described in Section 2.2.3.2, PCR optimization for this set of cloning primers 










Table 2.6: Oligonucleotide sequences of PCR primers for amplifying the gene insert 








CloningF 5’ TATTAACTTAAGGAATTATAACAAAGAAG 3’ 48.5 






















2.2.3.6.2 Cloning of PCR product 
TOPO TA Cloning® Kit (Invitrogen, Carlsbad CA, USA) was used and performed 
according to the manufacturer’s instructions. Briefly, the ligation reaction was carried 
out in a six microlitres reaction volume containing four microlitres of the PCR 
product, one microlitre of salt solution and one microlitre of TOPO® vector. The 
reaction mix was incubated at room temperature for 30min.  
The chemically competent cells used for transformation were One Shot® TOP10 
E.coli provided in the kit (Invitrogen, Carlsbad CA, USA). Two microlitres of the 
ligation reaction mix was added to the vial of competent cells and incubated on ice for 
30min. For the heat shock procedure, the whole set-up was placed in a 42oC waterbath 
for 30sec without shaking, and thereafter immediately put on ice for two minutes. To 
revive the cells, 250µl of SOC medium (Invitrogen, Carlsbad CA, USA) was added to 
the transformants and incubated at 37oC with horizontal shaking at 200rpm. Two 
volumes of 50µl transformant culture were then spread on Luria-Bertani (LB) agar 
containing 2.5% (w/v) of LB broth, Miller (Amresco, USA) and 1.5% (w/v) of 
nutrient agar (Pronadisa, Spain), supplemented with 50 µg/ml Kanamycin (Invitrogen, 
Carlsbad CA, USA). The plates were incubated overnight at 37°C for bacterial 
growth.  
Colony PCR was conducted using Plasmodium genus-specific primers PlasF and 
PlasR to screen the E. coli transformants for the gene insert. A single colony of the 
E.coli transformant was picked using a sterile 10 µl pipette tip and dipped into 20 µl 
PCR reaction mix containing 0.5 µM of each primer, 200 µM dNTP (Promega, WI, 
USA), 3mM MgCl2, 1x reaction buffer and 0.5 units Taq DNA polymerase (Promega, 
WI, USA).  Colony PCR was carried out with an initial denaturation at 95oC for 
34 
 
10min, followed by 35 amplification cycles of 95oC for 30sec, 57 oC for 30sec and 72 
oC for 30sec. The final elongation step was 72 oC for four minutes. At the end of the 
last cycle, the temperature was reduced to 20°C. The PCR products were analyzed by 
electrophoresis in 2% agarose gel, stained with Gel-RedTM (Biotium, Hayward, CA, 
USA), and observed under ultraviolet transillumination.  
 
2.2.3.6.3 Preparation of glycerol stocks 
Escherichia coli colonies, which contained the plasmid construct with the gene of 
interest, were each inoculated into five millilitres of LB broth, containing 2.5% of LB 
broth, Miller (Amresco, USA), supplemented with 50µg/ml of Kanamycin 
(Invitrogen, Carlsbad CA, USA).  The culture was grown at 37°C in a shaker 
incubator at 200rpm for at least eight hours for the subsequent preparation of glycerol 
stocks and plasmid extraction.  
Glycerol stocks were prepared for long-term storage of the individual bacterial 
cultures at -80oC. They were prepared by mixing 0.85ml of culture with 0.15ml of 
sterile glycerol (BDH, UK) in a 1.5ml microcentrifuge tube, followed by subsequent 
storage at -80°C. 
 
2.2.3.6.4 Extraction of plasmid DNA 
Extraction of plasmid DNA was carried out using PureLink™ Quick Plasmid 
Miniprep (Invitrogen, Carlsbad CA, USA) according to the manufacturer’s protocol. 
An overnight broth culture of the transformants was pelleted in a 1.5ml 
microcentrifuge tube. It was then resuspended by vortexing in 250µl of Resuspension 
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Buffer with RNase A. To lyze the cells, 250µl lysis buffer was added and mixed 
gently by inverting the tubes, followed by incubation at room temperature for three 
minutes. To precipitate the lyzed bacterial cells, 350µl of Precipitation Buffer was 
added and mixed immediately by inverting the tubes until the solution became 
homogenous. The mixture was then centrifuged at 12,000rpm for 10min to clarify the 
lysate from lysis debris. The entire solution was then transferred onto the PureLink ™ 
Quick Plasmid Miniprep Spin Column and centrifuged at 12,000rpm for one minute. 
The flow through was discarded and the collection tube was re-used.  Seven hundred 
microlitres of Wash Buffer was added onto the column and it was thereafter 
centrifuged at 12,000rpm for one minute. The flow through was discarded and the 
collection tube was re-used. To dry the column membrane, the column/collection tube 
was centrifuged at 12,000rpm for one minute. The collection tube was discarded and 
the column was transferred to a new 1.5ml microcentrifuge tube. Seventy-five 
microlitres of TE buffer was added directly to the membrane and the 
column/microcentrifuge tube was incubated at room temperature for one minute. To 
elute the plasmid DNA, the column/microcentrifuge tube was centrifuged at 
12,000rpm for two minutes. The eluted plasmid DNA was sent for sequencing at 1st 
BASE Pte Ltd (Singapore), using BigDye Terminator Cycle Sequencing kit (Applied 
Biosystems, USA). The remaining plasmid was stored at -20°C for later use. 
   
2.2.3.6.5 Dilution of stock plasmid for qPCR standards  
The stock plasmid DNA concentration was determined by measuring the absorbance 
at 260nm (A260) in a spectrophotometer (GeneQuant Pro, GE Healthcare, UK). For 
reliable DNA quantification, A260 readings should lie between 0.1 and 1.0. An 
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absorbance of 1 unit at 260nm corresponds to 50µg plasmid DNA per ml. Serial 
dilution of the stock plasmids was performed to obtain plasmid standards containing 
300,000, 30,000, 3,000, 300, 30, 3, 0.3, 0.03 and 0.003 copies of the gene insert. 
Firstly, the mass of single plasmid molecule was calculated using the formula:  
Mass = plasmid size (bp) x 1.096e-21 
Thereafter, the mass of plasmid DNA containing the required copy number of insert 
was calculated by multiplying the mass of single plasmid molecule with the required 
copy number. This calculated mass was divided by five microlitre (the volume 
transferred into each PCR reaction) to obtain the concentration of plasmid DNA 
needed to achieve the copy number of interest. With the concentration of the stock 
plasmid known after measurement by the spectrophotometer, serial dilution was 
conducted using TE buffer (QIAGEN, Hilden, Germany) to obtain the required  
plasmid DNA concentration of each copy number of interest, using the formular C1V1 
=C2V2. The nine quantification standards (equivalent from 0.003 to 30,000 genome 
copies per µl) were run in triplicates using real-time PCR for generation of standard 
curve. Using LightCycler® 480 Basic Software, a standard curve and the PCR 
efficiency was automatically calculated and displayed.  
 
2.2.4 Development of simian malaria species-specific nested PCR assay 
2.2.4.1 Optimization of annealing temperature for nest one Plasmodium genus-
specific primers 
The simian malaria species-specific nested PCR assay was designed based on the 
Plasmodium circumsporozoite protein (csp) gene. The nest one PCR assay involves 
the amplification of the full Plasmodium csp gene using oligonucleotide primers  
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PkCSP-F [45] and the PKCSPR2 [20] (refer to Table 2.7). The amplified products 
have an approximate size between 1,000bp to 1,200bp. PCR amplification was carried 
out using high fidelity DNA polymerase in a 50µl reaction volume. The reaction mix 
contained five microlitre of DNA template, 200 µM of dNTP (Promega, Madison WI, 
USA), 1x Phusion® Flash PCR Master Mix (Finnzymes, Espoo, Finland) and 0.5µM 
of each primers. PCR optimization was performed with annealing temperature of 
51oC to 61oC, with 2oC increment, using Veriti® Thermal Cycler (Applied 
Biostsyems, Foster City, CA USA). The cycling parameters were as followed: initial 
denaturation at 98oC for 10sec, followed by 44 cycles of 98oC for one second, 
different annealing temperatures for five seconds, and extension at 72 oC for 20 sec. 
Final elongation was at 72oC for two minutes.  
DNA extracted from blood of malaria-free human and macaque samples were used as 
negative controls. PCR products were visualized in 2% agarose gel and the optimum 
annealing temperature was determined. 
 
2.2.4.2 Nest two simian Plasmodium species-specific PCR assay 
2.2.4.2.1 Cloning and sequencing of the simian malaria parasites’ csp genes  
Cloning and sequencing of the csp genes of the five simian malaria parasites were 
conducted to obtain the complete gene sequence for the design of simian malaria 
species-specific primers. 
Cloning was conducted using Zero Blunt® PCR Cloning Kit (Invitrogen, Carlsbad 
CA, USA) and the cloning procedures described in Section 2.2.3.6.2 were used. For 
colony PCR of the E. coli transformants, PCR reaction mix and cycling parameters  
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Table 2.7: Oligonucleotide sequences of PCR primers used for amplifying the csp 
gene  
Primer name Sequence 
PkCSP-F 5’ TCCTCCACATACTTAATACAAGA 3’ 


















described in Section 2.2.3.6.2 were used, with PkCSP-F and PKCSPR2 as primers, 
and an annealing temperature of 55oC and extension of one minute.  
Positive clones were inoculated into five millitres of LB broth, containing 2.5% of LB 
broth, Miller (Amresco, USA), supplemented with 50µg/ml of Kanamycin 
(Invitrogen, Carlsbad CA, USA). The culture was grown at 37°C in a shaker 
incubator at 200rpm for at least eight hours. Plasmids of the individual bacterial 
culture were extracted using PureLink™ Quick Plasmid Miniprep (Invitrogen, 
Carlsbad CA, USA) as described in Section 2.2.3.6.4. 
Sequencing of the csp gene was conducted by a commercial company, 1st BASE Pte 
Ltd (Singapore), using BigDye Terminator Cycle Sequencing kit (Applied 
Biosystems, USA), using primers M13F(-20) (5’-GTAAAACGACGGCCAGT-3’) 
and M13R(-24) (5’ GGAAACAGCTATGACCATG 3’).  
 
2.2.4.2.2 Circumsporozoite protein gene sequence analysis  
The consensus sequence of csp genes from each simian Plasmodium species was 
obtained by assembling a contiguous sequence from the raw sequencing data using 
Seqman program (Lasergene, DNASTAR, USA). The 5’ and 3’ untranslated regions 
of the csp gene were removed to obtain the full coding sequence. As csp gene’s 
internal repeat region is not useful for simian malaria species-specific primer design, 
only the 456 nucleotide residues encoding the non-repeat N-terminal (first 195 
nucleotides of coding sequence) and C-terminal (261 nucleotides of coding sequence) 




2.2.4.2.3 Simian Plasmodium species-specific primer design  
In addition to the sequences generated, the csp gene sequences of other simian malaria 
parasites published in GenBank were also used in primer design. All sequences were 
aligned using MegAlign software (Lasergene, DNASTAR, USA). The species- 
specific PCR primers were designed based on the highly variable regions of the gene. 
The primers for the five simian Plasmodium species are listed in Table 2.8. The 
primer binding sites of each primer are illustrated in Appendix B.  
 
2.2.4.2.4 Optimization of nest two species-specific PCR assay 
To determine the optimum annealing temperature for the species-specific primers, 
nest two PCR assays were carried out using gradient PCR, with annealing 
temperatures listed in Table 2.8. These primers were tested against the four human 
and five simian Plasmodium species to ensure their species specificity. Table 2.9 and 
2.10 listed the nest two PCR reaction mix and cycling conditions used. All PCR 
products were analyzed by electrophoresis in 2% agarose gel, stained with Gel-RedTM 












Table 2.8: Oligonucleotide sequences of primers and the range of annealing temperatures used for PCR optimization  
Plasmodium 
species 










5’ – TTACCTACAGAAAATTAGATCTAC – 3’ 
5’ – GCCCTAATGAATTACTCACAAA – 3’ 







5’–TCTACCATT(A/G)GC(G/A)(C/T)CGAGTGGAG – 3’ 
5’ – AGGACTAACAATATGACTAGC – 3’ 







5’ – GGTGACAAAAAACCAGATA – 3’ 
5’-TCAGCTACTTAATTGAATAATGC-3’ 







5’ –CTTACCACCGAATGGAGTG – 3’ 
5’-AATAATGCTA(G/T)GACTA(G/A)CAATAT(T/G)ACTAC-3’ 









107 59, 61, 63, 65 
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RNase & DNase-free molecular grade water  
(Promega, Madison WI, USA) 
- 7.9 
5x reaction buffer, green (Promega) 1x 4.0 
MgCl2 25 mM (Promega) 2mM 1.6 
dNTP mix, 10 mM each  (Promega) 200µM 0.4 
Forward primer (2.5 mM) 0.25 µM 2.0 
Reverse primer (2.5 mM) 0.25 µM 2.0 
GoTaq DNA polymerase, 5U/ µl (Promega) 1.25U 0.1 
DNA template  - 2 
Total volume per reaction - 20.0 
 
 
Table 2.10: Cycling parameters for nest two PCR  
Steps Temperature/oC Time/s No. Cycles 
Initial denaturation 95 240 1 
Denaturation 95 30 
44 Annealing X 30 
Extension 72 30 
Final extension 72 120 1 
 








2.3.1 Use of primers PlasF and PlasR for conventional PCR 
Primer set PlasF and PlasR was able to detect DNA extracted from P. vivax of 
different parasite load, at all the tested annealing temperature. No amplification was 
observed with DNA from non-infected samples. All PCR reactions with P. vivax 
DNA yielded the expected product size of 180bp (Figure 2.2). Although stochastic 
cross-reaction was seen with malaria-negative macaque DNA at lower annealing 
temperature, the product size of this non-specific PCR reaction was incorrect, and this 
stochastic cross-reaction was abolished at higher annealing temperature.  
 
2.3.2 Comparison of sensitivity with nested PCR 
The Plasmodium genus-specific nested PCR assay designed by Singh and colleagues 
was reported to have a sensitivity of at least six parasites/µl of blood using DNA 
extracted from bloodspot [74]. Using DNA of P. vivax diluted to different 
parasitemia, the nested PCR assay produced a constantly high intensity of specific 
product band (as observed on gel electrophoresis) regardless of the parasite count in 
the samples, while the single run PCR showed a concentration-dependent intensity of 
the PCR band (Figure 2.3). The nested PCR assay was able to detect up to 0.006 
parasites/µl whereas the single conventional PCR assay using the newly designed 








Figure 2.2: PCR optimization of primer set PlasF and PlasR. Lane numbers (1 to 4) 
represent P. vivax of parasitemia 100p/µl, 0.3 p/µl, 0.06 p/µl, and malaria-negative 
macaque sample, respectively. Molecular size markers (100-basepair ladder) are 
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Figure 2.3: Comparison of sensitivity between single conventional PCR run using 
PlasF and PlasR (A) and the published nested PCR (B) in Plasmodium parasite 
detection. Molecular size markers are in lane M. Lane 1 to 18 are PCR amplification 
products using P. vivax of the following parasitemia (parasites/ µl): 100 (lane 1), 50 
(lane 2), 25 (lane 3), 12.5 (lane 4), 6.25 (lane 5), 3.13 (lane 6), 1.56 (lane 7), 0.78 
(lane 8), 0.39 (lane 9), 0.195 (lane 10), 0.0975 (lane 11), 0.0488 (lane 12), 0.024 (lane 
13), 0.012 (lane 14), 0.006 (lane 15), 0.003 (lane 16), malaria-negative human sample 
















2.3.3 Sensitivity of real-time PCR assay 
Real-time PCR using DNA of P. vivax with parastemia ranging from 0.003 to 100 
parasites/µl (Figure 2.4) was conducted to compare the sensitivity with the single 
conventional PCR run. Both real-time and conventional PCR assays were observed to 
have comparable sensitivity of detecting at least 0.003 parasites/µl of blood (Table 
2.11). In terms of sensitivity level in copy numbers, the real-time PCR assay was able 
to detect up to 0.3 copies/µl (Figure 2.5 and Table 2.12). However, only one out of the 
triplicates was found to be positive.  No amplification was detected using 0.03 and 
0.003 copies/µl.  
 
The slope of the standard curve describes the kinetics of the PCR amplification i.e. 
how fast the target DNA can increase with the amplification cycles (an indication of 
PCR efficiency). A perfect amplification will produce a standard curve with 
efficiency value of “two”, denoting that the amount of product doubles with each PCR 
cycle. The standard curve generated by the real-time PCR assay using primers PlasF 
and PlasR had an efficiency of 1.854 (Figure 2.6). This translates to an efficiency of 
92.7%, which is within the acceptable range of 90% to 100% [97].  
The error value (mean squared error of the single data points fit to the regression line), 
is a measure of the accuracy of the quantification result based on the standard curve. 
The error value of the standard curve produced is 0.013, which was within the 




Figure 2.4: Amplification curve of P. vivax with parasitemia of 0.003 to 
100parasites/µl. The graph was generated using LightCycler® 480 software. 
 
Table 2.11: Sensitivity of real-time PCR based on parasitemia 
Parasites/µl CP value 
100  21.46 
50  22.89 
25  23.91 
12.5  24.91 
6.25  26.05 
3.125  26.90 
1.56  27.89 
0.78  28.84 
0.39  30.00 
0.195  30.82 
0.0975  31.97 
0.04875  33.68 
0.024  34.61 
0.012  33.82 
0.006  35.33 




Figure 2.5: Amplification curve using plasmid controls of 0.003 to 300,000 copies. 
Genome concentration at 0.03 and 0.003 copies/µl were too low to be detected hence 

















Table 2.12: Sensitivity of real-time PCR based on copy numbers 
DNA copy numbers/ ul CP 
300,000  19.75 
300,000  19.71 
300,000  19.97 
30,000  23.50 
30,000  23.47 
30,000  23.45 
3,000  27.20 
3,000  27.12 
3,000  27.42 
300  30.94 
300  30.96 
300  30.74 
30  33.85 
30  34.17 
30  35.07 
3  36.44 
3  36.18 
3  36.16 
0.3  - 
0.3  - 
0.3  40.09 
0.03  - 
0.03  - 
0.03  - 
0.003  - 
0.003  - 
0.003  - 
 
 
Figure 2.6: Standard curve generated from the amplification profile of the SYBR 
green-based quantitative PCR of known genome copy numbers (3 to 300,000 copies/ 
µl) using the PlasF and PlasR primers. This standard curve was generated using 





2.3.4 Specificity of primers in detecting Plasmodium parasites 
To determine the Plasmodium genus specificity of primers PlasF and PlasR, real-time 
PCR assays were run against the four human and five simian malaria parasites’ and 
malaria-negative human and macaques’ DNA. Melting peak analysis revealed the 
clear detection of all the Plasmodium species controls, with an average melting 
temperature (Tm) of 80.32oC (Figure 2.7), though P. cynomologi showed a slightly 
higher Tm of 81.10ºC. None of the amplification reaction with malaria-negative 













Figure 2.7: Melting curve analysis with nine Plasmodium species controls and four 
malaria-negative human and macaques samples. Strong Tm peaks were seen using 
Plasmodium controls but not malaria-negative samples. The graph was generated 




Table 2.13: Tm values of PCR producted generated with each Plasmodium species. 
Samples Tm/oC 
P. falciparum 80.38 
P. malariae 80.42 
P. ovale 80.40 
P. vivax 80.23 
P. knowlesi 80.09 
P. coatneyi 80.32 
P. cynomolgi 81.10 
P. fieldi 80.32 
P. inui 80.60 
Negative human blood 1 - 
Negative human blood 2 - 
Negative monkey blood 1 - 






2.3.5 Development of simian malaria species-specific nested PCR assay 
2.3.5.1  Optimization of annealing temperature for nest one Plasmodium genus-
specific primers  
Primer set PkCSP-F and PkCSPR2 was able to detect the positive control (P. knowlesi 
DNA) at all the annealing temperatures tested (Figure 2.8). Although non-specific 
amplification of human and macaque DNA was observed at lower annealing 
temperature of 51oC and 53oC, these bands disappeared at higher temperature. Hence, 
55oC was used as the annealing temperature for the nest one amplification of the full 
csp gene. When tested against the four human and five simian malaria parasites’ 
DNA, these primers were found to be specific against P. knowlesi, P.coatneyi, P. 










Figure 2.8: Determination of optimum annealing temperature for nest one PCR assay. 
Lane numbers (1 to 3) represent P. knowlesi DNA, malaria-negative human and 
macaque DNA, respectively. Annealing temperatures tested were 51oC, 53oC, 55oC, 
57oC, 59oC and 61oC. Molecular size markers (1000-basepair ladder) are marked in 









Figure 2.9: Nest one PCR on the four human and five simian malaria parasite 
controls. The DNA templates used were as follows: P. falciparum (Pf), P. malariae 
(Pm), P. ovale (Po), P. vivax (Pv), P. knowlesi (Pk), P. coatneyi (Pct), P. cynomolgi 
(Pcy), P. fieldi (Pfi), P. inui (Pin), and malaria-negative human (-veHu) and macaque 
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2.3.5.2 Determination of optimum annealing temperature and specificity of nest 
two species-specific primers 
Each set of species-specific primers were tested against the nest one products of the 
four human and five simian Plasmodium species parasites, using annealing 
temperature listed in Table 2.8. The optimized annealing temperature for CspCOAT-
F1 and CspCOAT-R1, CspCYNO-F2.1 and CspCYNOR2, CspFIELDI-F2a and 
PKCSPR2, CspINUI-F2 and CspINUI-R1, and CspKnowlesiF and PKCSPR2 are 62 
ºC, 66ºC, 61ºC, 64ºC and 63ºC, respectively (Table 2.14). Using the optimized 
annealing temperature, the respective primer sets were highly specific towards the 
Plasmodium species they were designed for (see Figure 2.10). No amplification was 



























Table 2.14: Specificity of each primer pair in detecting the five simian Plasmodium 
parasites’ DNA at various annealing temperatures. The optimum temperature selected 
for each species-specific primer set is labelled with *. 
 
Primer Pair Plasmodium species tested 
 Annealing temperature(oC) 
Presence of amplified products 
  
58 60 62* 64 66 
CspCOAT-F1 
CspCOAT-R1 
P. coatneyi + + + +/- - 
P. cynomolgi - - - - - 
P. fieldi - - - - - 
P. knowlesi + +/- - - - 
P.inui -  -   -  - - 
  
58 60 62 64 66* 
CspCYNO-F2.1 
CspCYNOR2 
P. coatneyi - - - - - 
P. cynomolgi + + + + + 
P. fieldi + + + +/- - 
P. knowlesi - - - - - 
P.inui -  - -   - -  
  
 59 61* 63 65 
CspFIELDI-F2a 
PKCSPR2 
P. coatneyi  - - - - 
P. cynomolgi   - -   - -  
P. fieldi  + + +/- +/- 
P. knowlesi  - - - - 
P.inui   - -   - -  
  
58 60 62 64* 66 
CspINUI-F2 
CspINUI-R1 
P. coatneyi + + +/- - - 
P. cynomolgi - - - - - 
P. fieldi - - - - - 
P. knowlesi - - - - - 
P.inui  +  + +   + +/-  
  
 59 61 63* 65 
CspKnowlesiF 
PKCSPR2 
P. coatneyi  + +/- - - 
P. cynomolgi  - - - - 
P. fieldi  +/- - - - 
P. knowlesi  + + + +/- 
P.inui   -  -  - - 
 
“+” indicates strong band 




Figure 2.10: Specificity of each primer set in detecting the five simian Plasmodium 
species. The DNA templates used were P. falciparum (Pf), P. malariae (Pm), P. ovale 
(Po), P. vivax (Pv), P. knowlesi (Pk), P. coatneyi (Pct), P. cynomolgi (Pcy), P. fieldi 
(Pfi), P. inui (Pin), and malaria-negative human (-veHu) and macaque (-veMa).  
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The newly designed PlasF and PlasR are efficient and versatile primers that can be 
used for both conventional and real-time PCR methods. SYBR green-based and 
probe-based assays are the two commonly used real-time PCR methods to detect 
malaria parasites in blood samples. Between these methods, SYBR green assay is less 
expensive and precludes the use of complex light-sensitive probes.  Furthermore, 
probe-based method is sensitive to nucleotide base mismatch which may result in 
false negative results.  This is probable if an assay is designed to encompass multiple 
species within a genus, such as malaria.  With these in mind, the SYBR green-based 
assay was chosen instead.   
 
Primers PlasF and PlasR were designed based on the conserved region of both asexual 
and sexual stages of the Plasmodium SSU rRNA. When used in both PCR formats, 
the assay can detect at least 0.003parasites/µl, which is slightly higher than that of the 
published nested PCR assay. Furthermore, the ability of the SYBR green quantitative 
real-time PCR assay to detect less than three gene copies/µl also translates to a 
detection limit of less than one parasite/µl, as SSU rRNA is a multi-copy gene in 
Plasmodium parasites. Plasmodium species possess around four to eight SSU rRNA 
gene copies, with different copies expressed at different developmental stage of the 
parasite [99]. Hence, the sensitivity of the primers is most likely due to the multi-copy 
nature of the target gene and its short fragment length of 180bp [100].   
 
The quantitative feature of real-time PCR is an additional advantage over the 
conventional PCR assays and microscopy. Counting blood-stage parasites can be 
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time-consuming and the accuracy of quantification is affected by factors, such as 
number of fields observed under the microscopy and the experience of the 
microscopist.  Hence, due to these limitations, the standard curve for quantitative PCR 
was generated using plasmid standards rather than the counted parasitemia. In 
addition, as different Plasmodium species have different copy number of SSU rRNA 
genes, a standard curve generated using known parasitemia of one Plasmodium 
species will not be useful for quantification of another. Therefore, real-time PCR 
based on known copy numbers of SSU rRNA provides an unbiased and objective 
method in determining parasite load.  
 
Aside from its high sensitivity, the primers were able to detect all human and five 
simian malaria parasites with no cross-reactivity with human or long-tailed macaque 
DNA.  From the results obtained, the Tm averaged at 80.32 ºC with the exception of P. 
cynomolgi at 81.10ºC (Table 2.13). The difference in the Tm values between P. 
cynomolgi and the rest of the Plasmodium species is likely a result of sequence 
polymorphism in the region between the two primers’ binding sides, resulting in a 
difference in the GC content. Nonetheless, primers PlasF and PlasR are found to be 
highly specific for Plasmodium parasites, since no amplification reaction with 
malaria-negative human and macaque DNA produced a product with a melting 
temperature of 80ºC and above (Figure 2.7).  
 
When the current primers were used in both methods, complete amplification reaction 
was achieved in less than 1.5 hours, whereas, the published Plasmodium genus-
specific nested PCR assays can only be completed in around four hours. Moreover, as 
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this assay requires only a single round of amplification, the problem of cross 
contamination of PCR products (commonly associated with nested PCR assay), was 
significantly reduced. The ability of the primers, PlasF and PlasR, to detect all human 
malaria parasites coupled with its high sensitivity and short amplification time can be 
useful in the Plasmodium screening of large sample numbers. In comparison to the 
Plasmodium genus-specific nested PCR assay, disease surveillance using a single run 
PCR method will cost less especially when conducted in a hypoendemic area where 
malaria prevalence is low. The ability of the primers to be used in both conventional 
and real time PCR methods will also allow areas with different resources to have 
comparable malaria screening results.   
 
In contrast to the Plasmodium parasites screening PCR assays, the simian malaria 
species-specific nested PCR assay was designed based on the Plasmodium csp gene 
instead of the SSU rRNA gene.  The SSU rRNA gene is a multi-copy gene; each 
Plasmodium parasite species possesses several structurally distinct sets of SSU rRNA 
gene [99]. Hence, the design of five sets of simian Plasmodium species-specific 
primers using this gene may be challenging due to potential shared primer binding site 
between different species of malaria parasites. An example is the cross reaction of the 
published P. knowlesi specific primers (Pmk8 and Pmkr9) with the SSU rRNA gene 
segment of P. vivax [90], resulting in inaccurate identification of these parasites in 
human patients. Aside from being a single copy gene, the Plasmodium csp gene is a 
good target for the design of simian malaria species specific primers as csp sequences 




Overall, the newly developed nested PCR assay was found to be specific in 
distinguishing P. knowlesi, P. coatneyi, P. cynomolgi, P. fieldi and P. inui in macaque 
samples. Furthermore, primers CspKnowlesiF and PKCSPR2 were able to 
differentiate P. knowlesi from P. vivax in human infections. However, the sensitivity 
of this nested PCR assay could not be determined since the parasitemia of the simian 


















Prevalence of simian malaria parasites in Singapore’s macaques 
3.1 Introduction 
A surveillance study of malaria parasites in Malayan monkeys revealed that long-
tailed macaques (Macaca fascicularis) have the greatest prevalence of malaria as 
compared to other macaque species [22]. With an estimated population of 1400, long-
tailed macaque is the predominant macaque species in Singapore [101, 102]. They can 
be found in forest and near human habitations. In a previous study, this species of 
macaque was incriminated as the natural host of P. knowlesi infection for the human 
cases in Singapore [20]. As P. knowlesi infection in humans can be severe and 
potentially fatal [64, 65, 69], and other simian malaria parasites such as P. cynomolgi 
and P. inui, have been shown to be potentially infectious to humans, there is a need to 
determine the prevalence of simian malaria parasites in local macaques so that the risk 













3.2 Materials and methods 
3.2.1 Macaques’ blood samples 
Macaques in this surveillance study can be categorized into two groups – the wild 
(denoted with code WM) and the peri-domestic (denoded with code PM). Wild 
macaques were caught in the forests used for military training, an area which the 
general public had no access to. Hence, wild macaques had limited interaction with 
the general human population in Singapore. These macaques were caught under an 
operational surveillance program approved by the Singapore military’s joint medical 
committee and the DSO National Laboratory’s Institutional Animal Care and Use 
Committee. Two macaques were sampled from the mainland forest in November 
2007 upon notification of the first human knowlesi cases. Another 91 macaques were 
sampled from both the mainland (n=84) and offshore military forest (n=7) from April 
2009 to May 2011. On the other hand, peri-domestic macaques are found near human 
habitations and have closer interactions with the general public. Ten macaques were 
sampled from the central nature reserve park in January 2008. Another 55 were 
sampled from various parts of Singapore as part of a routine population control effort 
by the Agri-Food and Veterinary Authority of Singapore (AVA). 
All macaques caught were sent to AVA for age, sex and species characterization (see 
Appendix C and D for details of peri-domestic and wild macaques respectively). The 
age of macaques was estimated by dentition analysis [103].  Macaques age three years 
and below were classified as juveniles while those estimated to be age three years and 
above were classified as adults (Elvira Menguita, personal communication,1st Nov 
2011). Blood was collected in accordance with the ethical practices of AVA, and 
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EDTA blood samples were sent to EHI for analysis. Figure 3.1 illustrates the 
locations where macaques were sampled.    
 
              
3.2.2 DNA extraction and screening of macaques’ blood samples for simian 
malaria parasites 
DNA was extracted from the EDTA whole blood using protocol described in Section 
2.2.2.3. A rapid screening of malaria parasites was conducted using the real-time PCR 
described in Chapter Two. For samples positive for malaria parasites, species-specific 
PCR assay were subsequently used to identify the species of malaria parasites. PCR 
products were analyzed by electrophoresis in 2% agarose gel, stained with Gel-RedTM 




 Figure 3.1: Geographical representation of locations where macaques in this study 
were sampled. Area highlighted in green is the restricted access forest where wild 
long-tailed macaques were caught. Seven wild macaques were also sampled in Pulau 
Tekong (represented by a green point). Peridomestic macaques, on the other hand, 
were indicated with blue points. The size of the blue points was relative to the number 
of macaques sampled. Area highlighted in blue is the Central Nature Reserve, where 
ten peridomesticated macaques were sampled in 2008.  




3.3.1 Screening of macaques for Plasmodium parasites  
A total of 157 out of the 158 long-tailed macaques (Macaca fascicularis) sampled 
were screened for malaria parasites using real-time PCR assay. Of these, 92 and 65 
were wild and peri-domestic macaques, respectively. Of the 92 wild macaques, 71.7% 
(n=66) were infected with malaria parasites. Among these infected ones, 36.4% 
(n=24) were juveniles. This corresponds to a high infection rate of 80% (out of total 
30) among the juveniles macaques. Comparatively, the infection rate among the adult 
macaques is only 67.7%. None of the peri-domesticated macaques were found to be 
infected (Table 3.1). 
 
All the malaria positive samples were subsequently screened with the nested PCR to 
determine the species of Plasmodium parasites present. All five simian malaria 
parasites were detected, with P. knowlesi being the most prevalent (68.2%), followed 
by P. cynomolgi (60.6%), P. fieldi (16.7%), P. coatneyi (3.0%) and P. inui (1.5%). 
Furthermore, 62.5% (n=15) of the infected juvenile macaques harboured P. knowlesi. 
Plasmodium inui was only detected from the single malaria-positive macaque trapped 
in the military off-shore island.  
 
 In addition to the high malaria prevalence among the wild macaques, co-infection 
with multiple species of Plasmodium parasites was also observed. Dual infection was 
detected in 23 (34.8%) macaques, of which five were juveniles. Five (7.6%) 
macaques were infected with three Plasmodium species, of which two were juveniles 
Out of these 28 macaques with multiple infections, 25 (89.3%) had P. knowlesi 
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infection in them. Table 3.2 summarizes the malaria infections in the infected 


























Table 3.1: Summary of malaria infections in macaques sampled in this study 
Macaque population 
Infection rate of macaques screened 
N Infected Not infected 
n Percentage/% n Percentage/% 
Wild 
Adult 62 42 67.7 20 32.3 
Juvenile 30 24 80 6 20 






100 Juvenile 15 15 
Sub total 65 65 
Total Plasmodium positive: 66 
Total Plasmodium negative: 91 (26 wild, 65 peri-domestic) 
Total screened: 157 
 
 
Table 3.2: Breakdown of malaria infections in infected macaques 
Infection Plasmodium species 
Macaque type 
Total Adult Juveniles 
Single Pk 
11 9 20 




Pk, Pcy 11 4 15 
Pk, Pfi 3 0 3 
Pk, Pct 1 0 1 
Pk, Pin 1 0 1 
Pcy, Pfi 2 1 3 
 
  
Triple Pk, Pcy, Pfi 
3 1 4 
Pk, Pfi, Pct 0 1 1 
Total Plasmodium-positive   66 
 
Pct, Pcy, Pfi, Pin and Pk denodes Plasmodium coatneyi, P. cynomolgi, P. fieldi, P. 









The screening of 157 macaques sampled from different localities in Singapore 
revealed that all malaria-infected macaques were found in the restricted forest, an area 
with very limited access to the general public. On the other hand, none of the peri-
domestic macaques was found to be infected with malaria parasites. Similar 
observations were reported in Thailand and Malaysia [24, 28]. In both countries, all 
macaques caught in the urban areas were negative for malaria infection while those 
caught from the forest had a high infection rate. The reason for this observed 
difference was hypothesized to be the lack of competent vectors for simian malaria 
transmission in the urban areas.  
 
Overall infection rate was high, with 71.7% of the population sampled infected. Of 
these 57.6%, 34.8% and 7.6% were due to single, dual or triple infections, 
respectively. Among the infected wild macaques, Plasmodium knowlesi has the 
highest prevalence rate (68.2%). Other than P. knowlesi, these wild macaques also 
harboured P. coatneyi, P. cynomolgi, P. fieldi and P. inui. In addition, 80% of the 
juvenile macaques were found to be infected with malaria parasites. The high 
infection rate, especially among the juveniles, suggests a high intensity of 
transmission occurring in the forest. Although transplacental transmission in simian 
malaria parasites has not been reported, it cannot be ruled out that the high infection 
rates among juvenile macaques can be due to this. An understanding of the genotypic 
diversity of Plasmodium parasites found in these macaques might be able to shed 




Plasmodium cynomolgi is also a common malaria parasite found in local macaque 
population, with a prevalence rate of 60.6%. Together with P. inui, these malaria 
parasites were shown to be infectious to humans under laboratory conditions [35-39]. 
To date, there has been no report of naturally-acquired human infections with these 
parasites. One possible reason could be misdiagnosis due to their overlapping 
morphological characteristics with the human malaria parasites. Therefore, the simian 
malaria species-specific PCR assay will be useful in distinguishing these zoonotic 
malaria infections. 
 
Although none of the peri-domesticated macaques were infected with malaria, we can 
only conclude that the risk of a zoonotic transmission is low but not totally 
diminished. It is possible for the wild macaques in the restricted-access forest to 
migrate out to areas with human habitations, although they generally inhabited in the 
restricted-access forest, an area restricted to the general public. However, the actual 
risk of simian malaria transmission to humans could not be determined since the 
vector involved in the transmission in Singapore is currently not known. In addition, 
the sampling of macaques in this study was carried out under the operations of the 
military and the national veterinary authority. Hence, no random selection of 
macaques sampling sites was performed and the areas where our macaques were 
caught from might not constitute the entire range of Singapore’s macaques’ 
distribution. Hence, it is possible that there may be other areas (not covered in this 
study), with simian malaria transmission occurring. From the current study, P. inui 
was only detected in one of the wild macaques sampled from an offshore military 
island. Although P. inui was not detected among the macaques from mainland 
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Singapore, we cannot conclude that this species of malaria parasite is absent as the 
sample of wild macaques obtained may not be representative of the total population.  
This study constitutes the first report of surveillance of simian malaria parasites in 
long-tailed macaques in Singapore. Although previous study had illustrated that wild 
long-tailed macaques were the reservoir hosts of human P. knowlesi infections [20], 
the current results showed that local long-tailed macaques also harbour  P. coatneyi, 




































Characterization of the circumsporozoite protein genes of Plasmodium species 
from Singapore’s macaques 
4.1 Introduction 
Sixty-six wild long-tailed macaques were screened positive for malaria parasites using 
real-time PCR (Chapter 3). With the use of nested PCR assay developed in this study, 
P. knowlesi, P. cynomolgi, P. fieldi P. coatneyi and P. inui were detected. To confirm 
the nested PCR results, at least one gene of the parasite is to be characterized. The 
circumsporozoite protein (csp) gene is a gene which has been proven useful for the 
phylogenetic inferences of Plasmodium parasites. It produces a phylogenetic tree with 
topology similar to one constructed using the SSU rRNA gene sequence [96]. As it is 
an attractive candidate for malaria vaccine development due to its high immunogenic 
nature, there are more nucleotide sequence information on this gene in the GenBank 
as compared with other antigen-coding Plasmodium gene [104]. It is thus particularly 
useful for phylogenetic inferences.  
 
The csp gene is a single copy gene which encodes for an antigenic protein that covers 
the entire surface of the sporozoites [96, 105]. It is composed of a variable central 
region of repeats, flanked by two conserved motifs known as region I and region II-
plus, located at the amino- and carboxyl-terminal ends of the gene, respectively [96, 
106, 107]. Region I is based on the short amino acid motif KLKQP and this motif can 
be found in almost all mammalian Plasmodium parasites described thus far. On the 
other hand, region II-plus is a 20-amino acid motif 




Figure 4.1: A schematic diagram illustrating the anatomy of the Plasmodium csp 
gene. The variable central repeat region is flanked by two conserved motifs (region I 
and region II-plus) at the amino- and carboxyl-terminal ends, respectively. Region I 
and Region II-plus is denoted by RI and RII-plus. For phylogenetic analysis, only the 
first 195 from the non-repeat N-terminal and the last 256 nucleotides from the C-




















human thromospondin [106]. Both regions have been described to be important for 
the sporozoites’ invasion into the mammalian host’s hepatocyte cells [96, 108]. 
Subsequent studies had also revealed the potential role of region II-plus in sporozoite 
motility and invasion into mosquito salivary glands [106, 109]. 
 
Conversely, the variable central repeat region is made up of short amino acid residues 
which are tandemly repeated, making the circumsporozoite protein highly 
immunogenic. The length of a repeat unit and the number of repeats differ across and 
within species, making the size of a full csp gene highly variable [105]. As such, only 
the non-repeat regions at the N- and C-terminal were used for sequence alignment and 
phylogenetic analysis (Figure 4.1). Although the exact function of the repeat region is 
unknown, it has been hypothesized that the peptide repeats may act as a “smoke 
screen” to evade host immune system during the sporozoites’ invasion [105]. 
 
In this study, the csp gene was used to determine the phylogenetic relationship of 
malaria parasites detected from the long-tailed macaques. This gene has been used in 
phylogeny studies to understand the evolutionary history and relatedness of different 
primate malaria parasites [25, 104, 110]. Since csp is a single copy gene, each csp 
sequence is representative of a single Plasmodium parasite isolate. Hence, 
characterization of the csp gene could provide an indication on the genetic diversity of 
the Plasmodium parasites in our macaque samples. Moreover, this gene has also been 
used in the molecular epidemiological investigation of human knowlesi cases [20, 24, 
25]. Characterization of Plasmodium csp gene from humans and macaques will aid 




4.2 Materials and methods 
4.2.1 Isolates used for csp gene characterization 
The csp genes of malaria parasites from 15 wild long-tailed macaques, denoted as 
SG/EHI/WM01/Y07, SG/EHI/WM02/Y07, SG/EHI/WM04/Y09, 
SG/EHI/WM05/Y09, SG/EHI/WM11/Y09, SG/EHI/WM15/Y09, 
SG/EHI/WM16/Y09, SG/EHI/WM17/Y09, SG/EHI/WM18/Y09, 
SG/EHI/WM26/Y09, SG/EHI/WM33/Y09, SG/EHI/WM35/Y09, 
SG/EHI/WM42/Y10, SG/EHI/WM44/Y10 and SG/EHI/WM91/Y11, and together 
with those obtained from the LRDU of the Malaria branch, Division of Parasitic 
Diseases and Malaria, CDC, USA were characterized. The P. knowlesi csp gene 
sequences obtained from the human cases isolated in 2007 (SG/EHI/H1/Y07, 
SG/EHI/H2/Y07, SG/EHI/H7/Y07) and 2008 (SG/EHI/H24/Y08), were analyzed. In 
addition, two local knowlesi cases imported from peninsular Malaysia reported in 
2009 were also included in the analysis. The full csp gene sequences of these isolates, 
together with their GenBank accession numbers were listed in Appendix E.  
 
4.2.2  Cloning of the Plasmodium csp genes 
Amplification of the Plasmodium csp gene was carried out using the protocol 
described in Section 2.3.5. For cloning of blunt-end PCR products, the Zero Blunt® 
PCR Cloning Kit (Invitrogen, Carlsbad CA, USA) was used, with reference to the 
methods described in Section 2.2.3.6.2.  At least 80 E. coli transformants were 




For macaque samples co-infected with two or more species of malaria parasites, a 
second round PCR was performed on the products of the colony PCR to screen for the 
relevant simian malaria species in each monkey.  The amplification parameters and 
reaction mix followed that described in Section 2.2.4.1.4, using the appropriate set of 
simian malaria species-specific primers and its optimized annealing temperature. 
Upon screening, at least ten transformants of each Plasmodium species from each 
human or macaque samples were selected for sequencing. 
 
4.2.3 Preparation of glycerol stocks and plasmid DNA extraction 
Glycerol stocks of transformants containing the correct csp inserts were prepared 
using methods described in Section 2.2.3.6.3. 
Extraction of plasmid DNA was carried out using PureLink™ Quick Plasmid 
Miniprep (Invitrogen, Carlsbad CA, USA) according to the manufacturer’s protocol 
(Section 2.2.3.6.4).  
 
4.2.4  Sequencing of the csp gene 
Sequencing of the csp genes was conducted, by a commercial company (1st BASE Pte 
Ltd., Singapore), according to the BigDye Terminator Cycle Sequencing kit (Applied 
Biosystems, USA) protocol. The primers used for the sequencing of the complete csp 





Table 4.1: Oligonucleotide sequences of primers used in the sequencing of the csp 
gene  
Primers Direction Oligonucleotide sequences 
M13F (-20) Forward 5' GTAAAACGACGGCCAGT 3' 
M13R (-24) Reverse 5' GGAAACAGCTATGACCATG 3' 
CSP Internal Repeat F Forward 5’ CGAGGCAGAGGACTTGGTGA 3’ 






















4.2.5 DNA sequence analysis 
The consensus sequence of csp gene from each Plasmodium species was obtained by 
assembling a contiguous sequence from the raw sequencing data using Seqman 
program (Lasergene, DNASTAR, USA). The untranslated regions of the csp gene 
were removed to obtain the full coding gene sequence. Only the sequence encoding 
the non-repeat N-terminal (first 195 nucleotides of coding sequence) and C-terminal 
(261 nucleotides of coding sequence) of the csp gene was aligned [45, 96] using 
MegAlign software (Lasergene, DNASTAR, USA). Transformants representative of 
each sequence polymorphism were selected for subsequent phylogenetic and full csp 
gene analysis. Complete csp sequences from the GenBank database (Table 4.2) were 
also retrieved to compare and analyse with the sequences obtained from this study.  
 
To analyse the repeat region, the csp gene sequences were translated into amino acids 
using the EditSeq software (Lasergene, DNASTAR, USA).  The entire repeat region 
of the csp gene was determined based on the maximum number of amino acid that 
formed a tandem repeat motif. To determine the polymorphisms within the repeat 
region of each Plasmodium species, unique amino acid motif sequence were assigned 









Table 4.2: List of GenBank csp sequences used in the phylogenetic analysis 
Plasmodium species Accession 















































P.knowlesi, Nuri M11031 Peninsular Malaysia Macaca fascicularis [115] 
P. knowlesi, MPRK13 EU687469 Peninsular Malaysia H. sapiens [24] 
P. knowlesi, M197 EU821336 Peninsular Malaysia M. fascicularis [24] 





















P. cynomolgi, Berok 
 











P. coatneyi, Hackeri 
 






















P. inui FJ009512 Peninsular Malaysia M. fascicularis [24] 
P. inui, strain Taiwan II FN597613 Taiwan M. cyclopis [117] 
P. inui, strain Taiwan I 
 

































































4.2.6 Phylogenetic analysis 
The neighbour-joining (NJ) [121] and maximum-likelihood (ML) [122] method were 
used to analyze the csp gene sequences of all Plasmodium species obtained from 
long-tailed macaques and knowlesi patients. Phylogenetic analysis was carried out 
using MEGA version 5.0 ([123]; http://www.megasotfware.net).  For both NJ and 
ML method, Kimura-parameter model was used in all analyses, including transition 
and transversion. Internal node reliability was measured by the bootstrap method after 




4.3.1 Cloning and sequencing of Plasmodium species csp genes 
Plasmodium csp gene from 15 long-tailed macaques, four locally-acquired and two 
imported human knowlesi cases were amplified and cloned.  The presence of 
Plasmodium csp genes further confirmed the presence of simian malaria parasites in 
these samples. The number of transformant screened by PCR for each sample and 
those chosen for complete sequencing are listed Table 4.3. At least 80 and 100 
transformants for samples with single and mixed infection, respectively, were 
randomly screened by PCR using primers PKCSP-F and PKCSPR2. However, for 
SG/EHI/WM15/Y09 and SG/EHI/WM91/Y11, despite screening more than 500 
transformants, none was found to contain inserts containing P. coatneyi and P. 





Table 4.3: Summary of number of E.coli transformants of each isolate analyzed by 
colony PCR, and the code of transformants selected for complete csp gene analysis 








Code of transformants for 
phylogenetic and full sequence 
analysis  
SG/EHI/H01/Y07 90 Pk SG/EHI/H1/Y07-15 
SG/EHI/H02/Y07 85 Pk SG/EHI/H2/Y07-12 
SG/EHI/H07/Y07 80 Pk SG/EHI/H7/Y07-01 
SG/EHI/H24/Y08 80 Pk SG/EHI/H24/Y08-10 
SG/EHI/H1-im/Y09 102 Pk SG/EHI/H1-im/Y09 -17, 25, 80, 95, 102 
SG/EHI/H2-im/Y09 105 Pk SG/EHI/H2-im/Y09 -3,7, 11, 12, 18 
SG/EHI/WM01/Y07 150 Pk SG/EHI/WM01/Y07-6 
Pfi SG/EHI/WM01/Y07-23 
SG/EHI/WM02/Y07 120 Pk SG/EHI/WM02/Y07-1, 39 
Pcy SG/EHI/WM02/Y07-110 
SG/EHI/WM04/Y09 80 Pk SG/EHI/WM04/Y09-8, 9, 12, 13, 14, 15 
SG/EHI/WM05/Y09 160 
Pk SG/EHI/WM05/Y09-70, 79 
Pcy SG/EHI/WM05/Y09-65 
Pfi SG/EHI/WM05/Y09-68 





SG/EHI/WM16/Y09 100 Pk SG/EHI/WM16/Y09-85 
Pcy SG/EHI/WM16/Y09-2, 34 
SG/EHI/WM17/Y09 80 Pk SG/EHI/WM17/Y09-4, 30 
SG/EHI/WM18/Y09 100 Pcy SG/EHI/WM18/Y09-24 
Pfi SG/EHI/WM18/Y09-92 
SG/EHI/WM26/Y09 80 Pk 
SG/EHI/WM26/Y09-1, 13, 47, 60, 98, 
123 
SG/EHI/WM33/Y09 87 Pk SG/EHI/WM33/Y09-39 
Pcy SG/EHI/WM33/Y09-47 
SG/EHI/WM35/Y09 80 Pk SG/EHI/WM35/Y09-38, 74 
SG/EHI/WM42/Y10 80 Pcy SG/EHI/WM42/Y10-1 
SG/EHI/WM44/Y10 105 Pcy SG/EHI/WM44/Y10-3, 30 
Pfi SG/EHI/WM44/Y10-64 
SG/EHI/WM91/Y11 320 Pin SG/EHI/WM91/Y11-61, 73 
Pk - 
 
Pct, Pcy, Pfi, Pin and Pk denodes Plasmodium coatneyi, P. cynomolgi, P. fieldi, P. 






4.3.2 Phylogenetic analyses of the csp genes 
The phylogenetic trees constructed using NJ and ML methods are shown in Figure 4.2 
and 4.3, respectively. Both methods produced phylogenetic trees of similar topology, 
and demonstrated that simian malaria parasites isolated from Singapore samples can 
be clustered into four major clades, namely P. knowlesi, P. cynomolgi, P. fieldi and P. 
inui.  
 
Circumsporozoite protein gene sequences from transformants derived from 11 
monkeys and the six human knowlesi cases formed a cluster with five subclades 
within the P. knowlesi clade (Figure 4.4).  The csp gene sequences derived from the 
four locally-acquired human knowlesi cases were found to be identical to those 
isolated from some of the long-tailed macaques caught in the restricted forest. On the 
other hand, the csp gene sequences derived from two human knowlesi cases, which 








Figure 4.2: Phylogenetic tree of the non-repeat region of the Plasmodium species csp 
genes, constructed using the neighbour-joining method. Clones colored red are 
isolates from human samples. Clones underlined had shared genotype. Figures on the 
branches are bootstrap percentages based on 1000 replicates, and only bootstrap 









Figure 4.3: Phylogenetic tree of the non-repeat region of the Plasmodium species csp 
genes, constructed using the maximum-likelihood method. Clones colored red are 
isolates from human samples. Clones underlined had shared genotype. Figures on the 
branches are bootstrap percentages based on 1000 replicates, and only bootstrap 





The sequences of the non-repeat region of transformants SG/EHI/H7/Y07-1 were 
found to be identical to SG/EHI/WM2/Y07-39 and SG/EHI/WM1/Y07-6, while 
SG/EHI/H24/Y08-10 was found to be identical to SG/EHI/WM17/Y09-30 and 
SG/EHI/WM26/Y09-13. Similarly, the non-repeat region of transformants 
SG/EHI/H1/Y07-15, SG/EHI/H2/Y07-12, SG/EHI/WM02/Y07-1, 
SG/EHI/WM11/Y09-74, SG/EHI/WM33/Y09-39 and SG/EHI/WM35/Y09-74 were 
also found to be identical. SG/EHI/WM15/Y09-149, SG/EHI/WM4/Y09-12 and 
SG/EHI/WM16/Y09-85 were also found to have indistinguishable non-repeat regions. 
Interestingly, the non-repeat P. knowlesi csp sequence of human and macaque 
samples were identical although they were collected across years; human samples in 
2007 (SG/EHI/H01/Y07, SG/EHI/H02/Y07 and SG/EHI/H07/Y07) and 2008 
(SG/EHI/H24/Y08), while most of the macaques in this study were surveyed in 2009 
(Appendix D).  
 
Nine csp gene sequences from seven long-tailed macaques (SG/EHI/WM02/Y07, 
SG/EHI/WM05/Y09, SG/EHI/WM16/Y09, SG/EHI/WM18/Y09, 
SG/EHI/WM33/Y09, SG/EHI/WM42/Y10, and SG/EHI/WM44/Y10) were found to 
cluster in the P. cynomolgi clade. Within the P. cynomologi cluster, three distinct sub-
clades with high bootstrap value were observed (Figure 4.2 and 4.3). Transformants 
derived from SG/EHI/WM05/Y09 and  SG/EHI/WM44/Y10 were found to cluster in 
a subclade within P. cynomolgi clade, while transformants derived from 
SG/EHI/WM16/Y09 and SG/EHI/WM33/Y09, and SG/EHI/WM02/Y07, 




Figure 4.4: Phylogenetic tree of the non-repeat region of the P. knowlesi csp genes, 
constructed using the neighbour-joining method. Clones colored red are isolates from 
human samples. Figures on the branches are bootstrap percentages based on 1000 
replicates, and only bootstrap percentages above 70% are shown. 
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The P. fieldi clade consisted of one transformant each derived from 
SG/EHI/WM01/Y07, SG/EHI/WM05/Y07, SG/EHI/WM15/Y09, 
SG/EHI/WM18/Y09 and SG/EHI/WM44/Y10.  Transformants that shared identical 
nucleotide sequences of the non-repeat region (SG/EHI/WM01/Y07-23 with 
SG/EHI/WM05/Y09-68, and SG/EHI/WM15/Y09-163 with SG/EHI/WM18/Y09-92) 
were clustered into one subclade (Figure 4.2 and 4.3). On the other hand, the P. inui 
clade consisted of two transformants derived from SG/EHI/WM91/Y11 macaque.  
Each transformant formed different subclade with high bootstrap values (Figure 4.2 
and 4.3).   
 
4.3.3 Polymorphisms of the non-repeat regions of the Plasmodium species csp 
gene 
4.3.3.1 P. knowlesi transformants 
The 456 nucleotides sequence coding the non-repeat regions of the csp gene from 
Singapore isolates were aligned with the P. knowlesi H strain as reference (Table 4.4).  
Only single P. knowlesi csp genotypes were detected in each local human case, while 
the number of genotypes presents in each monkey varied from one to six. 
SG/EHI/WM04/Y09 and SG/EHI/WM26/Y09 harbored six different genotypes each, 
while two genotypes were detected for monkey SG/EHI/WM35/Y09 and 
SG/EHI/WM17/Y09. Single genotypes were found in the rest of the monkeys.  
Interestingly, five genotypes were detected from each of the imported human 
knowlesi cases. Comparison of Singapore’s P. knowlesi isolates with the reference H 
strain showed 53 polymorphic sites. Of these, 24 were due to synonymous mutations  
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Table 4.4: Gene polymorphisms based on the 456 nucleotide residues encoding the 
non-repeat region of the csp gene of P. knowlesi malaria parasites from Singapore’s 
human and long-tailed macaques (in bold). Nucleotide positions are numbered 
vertically above the polymorphic sites. Dots indicate identical nucleotide residues. 
Highlighted areas denote non-synonymous mutations.  
Strain/ clone Nucleotide position 
                  1 1 1 1 1 1 1 1 1 1 1 
1 4 6 7 7 8 9 9 1 1 2 2 2 4 4 5 5 5 6 
5 3 9 1 2 5 5 3 4 1 5 2 5 6 8 9 0 2 6 2 
P. knowlesi H  A A T C T T T C A A T A T A C A G A G A 
P. knowlesi Nuri  . . . . . . . A . . . . . . G C A . A . 
SG/EHI/H1/Y07-15 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/H2/Y07-12 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/H7/Y07-1 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/H24/Y08-10 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/H1-im/Y09-17 G . . . . . . . . . . . . . G C A . A . 
SG/EHI/H1-im/Y09-25 . . . . . . . . . . . . . . G C A . A . 
SG/EHI/H1-im/Y09-80 . . . . . . . . . . . . . . G C A . A . 
SG/EHI/H1-im/Y09-95 . . . . . . . . . . C . . . G C A . A . 
SG/EHI/H1-im/Y09-102 . . . . . . . . . . . . . . G C A . A . 
SG/EHI/H2-im/Y09-3 . . . . . . . . . . . . . . G C A . A . 
SG/EHI/H2-im/Y09-7 G . . . . . . . . . . . . . G C A . A . 
SG/EHI/H2-im/Y09-11 . . . . . . . . . . . . . G G C A . A . 
SG/EHI/H2-im/Y09-12 . . . . . . . . . . . . . . G C A . A . 
SG/EHI/H2-im/Y09-18 . . . . . . A . . . . . . . G C A . A . 
SG/EHI/WM01/Y07-6 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM02/Y07-1 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM02/Y07-39 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM04/Y09-8 . . . T . . . . . G . G . . G C A . A . 
SG/EHI/WM04/Y09-9 . . C T . . . . . . . G . . G C A . A . 
SG/EHI/WM04/Y09-12 . . . T . . . . . . . G . . G C A . A . 
SG/EHI/WM04/Y09-13 . . . T . . . . . . . G . . G C A . A G 
SG/EHI/WM04/Y09-14 . . . T . . . . . . . G . . G C A . A . 
SG/EHI/WM04/Y09-15 . . . T . . . . G . . G . . G C A . A . 
SG/EHI/WM05/Y09-70 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM05/Y09-79 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM11/Y09-74 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM15/Y09-149 . . . T . . . . . . . G . . G C A . A . 
SG/EHI/WM16/Y09-85 . . . T . . . . . . . G . . G C A . A . 
SG/EHI/WM17/Y09-4 . . . . . . . . . . . . C . G C A . . . 
SG/EHI/WM17/Y09-30 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM26/Y09-1 . . . . . C . . . . . . . . G C A . . . 
SG/EHI/WM26/Y09-13 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM26/Y09-47 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM26/Y09-60 . . . . . . . . . . . . . . G C A G . . 
SG/EHI/WM26/Y09-98 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM26/Y09-123 . . . . C . . . . . . . . . G C A . . . 
SG/EHI/WM33/Y09-39 . . . . . . . . . . . . . . G C A . . . 
SG/EHI/WM35/Y09-38 . T . . . . . . . . . . . . G C A . . . 





Table 4.4 continued. 
 
Strain/ clone Nucleotide position 
1 1 1 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 
9 9 9 0 0 0 1 1 2 5 7 9 0 0 0 0 0 0 1 1 
4 7 8 0 1 2 3 9 8 1 6 7 3 5 6 7 8 9 0 5 
P. knowlesi H  A C A A T G G T C C C T A A A G C T C A 
P. knowlesi Nuri  . . . . . . . . . . . A . . . . G . . . 
SG/EHI/H1/Y07-15 . . . . . . . . . . . . . G . C A G A T 
SG/EHI/H2/Y07-12 . . . . . . . . . . . . . G . C A G A T 
SG/EHI/H7/Y07-1 . . . . . . . . . . . . . .   . . . . . 
SG/EHI/H24/Y08-10 . . . . . . . . . . . . . . . . G . . . 
SG/EHI/H1-im/Y09-17 . . . . . . A . G T . . . G . . . . . . 
SG/EHI/H1-im/Y09-25 . . . . . . A C G T T . . G . . . . . . 
SG/EHI/H1-im/Y09-80 . . . . . . A . G T . . . G . . . . . . 
SG/EHI/H1-im/Y09-95 . . . . . . A . G T . . . G . . . . . . 
SG/EHI/H1-im/Y09-102 . . . . . . A . G T . . . G . . . . . . 
SG/EHI/H2-im/Y09-3 . . . . . . A . G T . . . G . . . . . . 
SG/EHI/H2-im/Y09-7 . . . . . . A . G T . . . G . . . . . . 
SG/EHI/H2-im/Y09-11 . . . . . . A . G T . . . G . . . . . . 
SG/EHI/H2-im/Y09-12 . . . . . . A . G T . . . G . . . . . . 
SG/EHI/H2-im/Y09-18 . . . . . . A . G T . . . G . . . . . . 
SG/EHI/WM01/Y07-6 . . . . . . . . . . . . . . . . . . . . 
SG/EHI/WM02/Y07-1 . . . . . . . . . . . . . G . C A G A T 
SG/EHI/WM02/Y07-39 . . . . . . . . . . . . . . . . . . . . 
SG/EHI/WM04/Y09-8 . . . . . . A . G . . . . G . . . . . . 
SG/EHI/WM04/Y09-9 . . . . . . A . G . . . . G . . . . . . 
SG/EHI/WM04/Y09-12 . . . . . . A . G . . . . G . . . . . . 
SG/EHI/WM04/Y09-13 . . . . . . A . G . . . . G . . . . . . 
SG/EHI/WM04/Y09-14 . . . . . . A . G . . . . G . . . . . G 
SG/EHI/WM04/Y09-15 . . . . . . A . G . . . G G . . . . . . 
SG/EHI/WM05/Y09-70 . . . . . . . . . . . . . . G . G . . . 
SG/EHI/WM05/Y09-79 G . . . . . . . . . . . . G . C A G A T 
SG/EHI/WM11/Y09-74 . . . . . . . . . . . . . G . C A G A T 
SG/EHI/WM15/Y09-149 . . . . . . A . G . . . . G . . . . . . 
SG/EHI/WM16/Y09-85 . . . . . . A . G . . . . G . . . . . . 
SG/EHI/WM17/Y09-4 . . . . . . . . . . . . . . . . G . . . 
SG/EHI/WM17/Y09-30 . . . . . . . . . . . . . . . . G . . . 
SG/EHI/WM26/Y09-1 . . . . . . . . . . . . . . . . G . . . 
SG/EHI/WM26/Y09-13 . . . . . . . . . . . . . . . . G . . . 
SG/EHI/WM26/Y09-47 . . G . . . . . . . . . . . . . G . . . 
SG/EHI/WM26/Y09-60 . . . . . . . . . . . . . G . . A . . T 
SG/EHI/WM26/Y09-98 . A T G A . . . . . . . . . . G . . . 
SG/EHI/WM26/Y09-123 . . . . . . . . . . . . . . . . G . . . 
SG/EHI/WM33/Y09-39 . . . . . . . . . . . . . G . C A G A T 
SG/EHI/WM35/Y09-38 . . . . . . . . . . . . . G . C A G A T 






Table 4.4 continued. 
  
  Nucleotide position 
Strain/ clone   
3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 4 
1 2 2 3 4 4 5 8 8 0 1 2 2 3 3 3 
7 1 6 2 3 8 7 0 4 1 2 0 6 1 5 9 
P. knowlesi H  G T A A A T G A C T T C C T A C 
P. knowlesi Nuri  . . . . . . . . . . . . . . . . 
SG/EHI/H1/Y07-15 . . . . . . . . . . . . . . . T 
SG/EHI/H2/Y07-12 . . . . . . . . . . . . . . . T 
SG/EHI/H7/Y07-1 . . . . . . . . . . . . . . . . 
SG/EHI/H24/Y08-10 . . . . . . . . . . . . . . . . 
SG/EHI/H1-im/Y09-17 A G . . . . A . T . . G A . . . 
SG/EHI/H1-im/Y09-25 A G . . . . A . T . . G A . . . 
SG/EHI/H1-im/Y09-80 A G . . . . A . T . . G A . . . 
SG/EHI/H1-im/Y09-95 A G . . . . A . T . . G A . . . 
SG/EHI/H1-im/Y09-102 A G . . . . A G T . . G A . G . 
SG/EHI/H2-im/Y09-3 A G . . G . A . T . . G A . . . 
SG/EHI/H2-im/Y09-7 A G . . . . A . T . A G A . . . 
SG/EHI/H2-im/Y09-11 A G G . . . . . T . . G A . . . 
SG/EHI/H2-im/Y09-12 A G . . . . A . T . . G A . . . 
SG/EHI/H2-im/Y09-18 A G . . . . A . T . . G A . . . 
SG/EHI/WM01/Y07-6 . . . . . . . . . . . . . . . . 
SG/EHI/WM02/Y07-1 . . . . . . . . . . . . . . . T 
SG/EHI/WM02/Y07-39 . . . . . . . . . . . . . . . . 
SG/EHI/WM04/Y09-8 A G . . . . A . T . . G . C . . 
SG/EHI/WM04/Y09-9 A G . . . . A . T . . G . . . . 
SG/EHI/WM04/Y09-12 A G . . . . A . T . . G . . . . 
SG/EHI/WM04/Y09-13 A G . . G . A . T . . G . . . . 
SG/EHI/WM04/Y09-14 A G . . . . A . T . . G . . . . 
SG/EHI/WM04/Y09-15 A G . G . . A . T C . G . . . . 
SG/EHI/WM5/Y09-70 . . . . . . . . . . . . . . . . 
SG/EHI/WM5/Y09-79 . . . . . . . . . . . . . . . T 
SG/EHI/WM11/Y09-74 . . . . . . . . . . . . . . . T 
SG/EHI/WM15/Y09-149 A G . . . . A . T . . G . . . . 
SG/EHI/WM16/Y09-85 A G . . . . A . T . . G . . . . 
SG/EHI/WM17/Y09-4 . . . . . . . . . . . . . . . . 
SG/EHI/WM17/Y09-30 . . . . . . . . . . . . . . . . 
SG/EHI/WM26/Y09-1 . . . . . . . . . . . . . . . . 
SG/EHI/WM26/Y09-13 . . . . . . . . . . . . . . . . 
SG/EHI/WM26/Y09-47 . . . . . . . . . . . . . . . . 
SG/EHI/WM26/Y09-60 . . . . . C . . . . . . . . . T 
SG/EHI/WM26/Y09-98 . . . . . . . . . . . . . . . . 
SG/EHI/WM26/Y09-123 . . . . . . . . . . . . . . . . 
SG/EHI/WM33/Y09-39 . . . . . . . . . . . . . . . T 
SG/EHI/WM35/Y09-38 . . . . . . . . . . . . . . . T 







while the rest were due to non-synonymous mutations.  Unique haplotypes CAGAT 
(at positions 307, 308, 309, 310 and 315) were detected in two human samples 
(SG/EHI/H1/07 and SG/EHI/H2/07) and five monkey samples (SG/EHI/WM02/Y07, 
SG/EHI/WM05/Y09, SG/EHI/WM11/Y09, SG/EHI/WM33/Y09 and 
SG/EHI/WM35/Y09). Both human samples and SG/EHI/WM02/Y07 were isolated in 
2007 while SG/EHI/WM05/Y09, SG/EHI/WM11/Y09, SG/EHI/WM33/Y09 and 
SG/EHI/WM35/Y09 were all isolated in 2009. Unique nucleotide sequence at 
position 308 (G) were found in nine transformants from one human 
(SG/EHI/H24/Y08-10) and four monkey (SG/EHI/WM05/Y09-70, 
SG/EHI/WM17/Y09-4/30, SG/EHI/WM26/Y09-1/98/47/123/134) samples. Two 
unique nucleotide sequences at position 61 (T) and 122 (G) was detected in eight 
transformants from three monkeys (SG/EHI/WM04/Y09-8/9/12/13/14/15, 
SG/EHI/WM15/Y09-149 and SG/EHI/WM16/Y09-85). Similarly, two unique 
nucleotide sequences at position 251 (T) and 426 (A) were also detected in both 
imported human knowlesi case. No unique polymorphism can be found in 
transformant SG/EHI/H7/Y07-1 and SG/EHI/WM02/Y07-39 and 
SG/EHI/WM01/Y07-6.  Interestingly, P. knowlesi transformants with shared unique 
haplotypes were found to cluster in the same subclade (Figure 4.4).   
 
The pair-wise divergence of different P. knowlesi transformants from both monkeys 
and human cases ranged from 0.2% to 4.8% (Table 4.5).
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Table 4.5: Percentage divergence of the non-repeat regions of the P. knowlesi clones calculated with the Kimura-2 parameter, using transitions and 
transversions.  
  
Isolate/ clone  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 
1 P. knowlesi H  ***                             








2.2 2.2 ***                           
4 SG/EHI/H1-im/Y09-17 3.4 3.1 3.8 ***                          
5 SG/EHI/H1-im/Y09-25 3.6 3.4 4.1 0.7 ***                         
6 SG/EHI/H1-im/Y09-95 3.4 3.1 3.8 0.4 0.7 ***                        
7 SG/EHI/H1-im/Y09-102 3.6 3.4 4.1 0.7 0.9 0.7 ***                       
8 SG/EHI/H2-im/Y09-3 3.4 3.1 3.8 0.4 0.7 0.4 0.7 ***                      
9 SG/EHI/H2-im/Y09-7 3.6 3.4 4.1 0.2 0.9 0.7 0.9 0.7 ***                     
10 SG/EHI/H2-im/Y09-11 3.4 3.1 3.8 0.9 1.1 0.9 1.1 0.9 1.1 ***                    
11 
SG/EHI/H1-im/Y09-80,  
SG/EHI/H2-im/Y09-12 3.1 2.9 3.6 0.2 0.4 0.2 0.4 0.2 0.4 0.7 ***                   





0.7 0.9 1.6 2.7 2.9 2.7 2.9 2.7 2.9 2.7 2.5 2.7 ***                 
14 SG/EHI/WM4/Y09-8 3.6 3.4 4.1 1.6 1.8 1.6 1.8 1.6 1.8 2 1.3 1.6 2.9 ***                
15 SG/EHI/WM4/Y09-9 3.4 3.1 3.8 1.3 1.6 1.3 1.6 1.3 1.6 1.8 1.1 1.3 2.7 0.7 ***               
16 SG/EHI/WM4/Y09-13 3.6 3.4 4.1 1.6 1.8 1.6 1.8 1.1 1.8 2 1.3 1.6 2.9 0.9 0.7 ***              
17 SG/EHI/WM4/Y09-14 3.4 3.1 3.6 1.3 1.6 1.3 1.6 1.3 1.6 1.8 1.1 1.3 2.7 0.7 0.4 0.7 ***             
18 SG/EHI/WM4/Y09-15 4.1 3.8 4.5 2 2.2 2 2.2 2 2.2 2.5 1.8 2 3.4 1.3 1.1 1.3 1.1 ***            
19 SG/EHI/WM5/Y09-70 1.1 0.9 1.8 3.1 3.4 3.1 3.4 3.1 3.4 3.1 2.9 3.1 0.4 3.4 3.1 3.4 3.1 3.8 ***           





3.1 2.9 3.6 1.1 1.3 1.1 1.3 1.1 1.3 1.6 0.9 1.1 2.5 0.4 0.2 0.4 0.2 0.9 2.9 3.8 ***         





0.9 0.7 1.6 2.9 3.1 2.9 3.1 2.9 3.1 2.9 2.7 2.9 0.2 3.1 2.9 3.1 2.9 3.6 0.2 1.8 2.7 0.2 ***       
24 SG/EHI/WM26/Y09-1 1.1 0.9 1.8 3.1 3.4 3.1 3.4 3.1 3.4 3.1 2.9 3.1 0.4 3.4 3.1 3.4 3.1 3.8 0.4 2 2.9 0.4 0.2 ***      
25 SG/EHI/WM26/Y09-47 1.1 0.9 1.8 3.1 3.4 3.1 3.4 3.1 3.4 3.1 2.9 3.1 0.4 3.4 3.1 3.4 3.1 3.8 0.4 2 2.9 0.4 0.2 0.4 ***     
26 SG/EHI/WM26/Y09-60 2.7 2.7 0.4 4.3 4.5 4.3 4.5 4.3 4.5 4.3 4.1 4.3 2 4.5 4.3 4.5 4.1 5 2.2 0.7 4.1 2.2 2 2.2 2.2 ***    
27 SG/EHI/WM26/Y09-98 1.8 1.6 2.5 3.8 4.1 3.8 4.1 3.8 4.1 3.8 3.6 3.8 1.1 4.1 3.8 4.1 3.8 4.5 1.1 2.7 3.6 1.1 0.9 1.1 1.1 2.9 ***   
28 SG/EHI/WM26/Y09-123 1.1 0.9 1.8 3.1 3.4 3.1 3.4 3.1 3.4 3.1 2.9 3.1 0.4 3.4 3.1 3.4 3.1 3.8 0.4 2 2.9 0.4 0.2 0.4 0.4 2.2 1.1 ***  
29 SG/EHI/WM35/Y09-38 2.5 2.5 0.2 4.1 4.3 4.1 4.3 4.1 4.3 4.1 3.8 4.1 1.8 4.3 4.1 4.3 3.8 4.8 2 0.4 3.8 2 1.8 2 2 0.7 2.7 2 *** 
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4.3.3.2 P. cynomolgi transformants 
Circumsporozoite protein gene sequence alignment between transformants from seven 
long-tailed macaques and P. cynomolgic Ceylon strain (as reference) disclosed 31 
polymorphic sites. Twelve of these polymorphic sites were due to synonymous 
mutations while 19 were non-synonymous mutations (Table 4.6). Pair-wise sequence 
divergence between these transformants ranged from 0.2% to 4.5% (Table 4.7). After 
the sequence were aligned, there were two genotypes each for SG/EHI/WM16/Y09 
and SG/EHI/WM44/10, while only one genotype each were observed for 
SG/EHI/WM02/Y07, SG/EHI/WM05/Y09, SG/EHI/WM18/Y09, 
SG/EHI/WM33/Y09 and SG/EHI/WM42/Y10. Unique haplotypes GCGG (at 
positions 21, 63, 79 and 119) were detected in SG/EHI/WM16/Y09 and 
SG/EHI/WM33/Y09, while haplotypes AACA (at positions 247, 250, 251 and 302) 







Table 4.6: Gene polymorphisms based on the 456 nucleotide residues encoding the non-repeat region of the csp gene of P. cynomolgi malaria 
parasites from Singapore’s long-tailed macaques (in bold). Nucleotide positions are numbered vertically above the polymorphic sites. Dots 
indicate identical nucleotide residues. Highlighted areas denote non-synonymous mutations.  
 
 Nucleotide position 
Strain/ clone 
 
             
1 1 2 2 2 2 2 2 2 2 2 3 3 3 3 3 4 4 
 
1 2 2 3 5 5 6 6 6 6 7 8 8 1 3 0 1 1 4 4 5 5 5 6 0 1 4 5 6 0 1 
 
4 1 3 9 4 6 1 3 6 9 9 7 9 9 8 3 0 4 4 7 0 1 2 6 2 1 4 8 0 8 8 
P. cynomolgi, Ceylon A A C G C G C G G A C C A A C T T A A G G T C G G A C A T C G 
P. cynomolgi, Berok . G T T T C A C C G . T G . A C C . C . . . T . G G T . . T C 
SG/EHI/WM02/Y07-110 T . . . T C A C C G G . G . . . . C . . . . . . . G . . . T . 
SG/EHI/WM05/Y09 -65 T . . . T C A C C G G . G . A . . C . A A C . . A . T G A T . 
SG/EHI/WM16/Y09-2 T G . . . . . C . . G . . G A . . . . . . . . A . G . . . T . 
SG/EHI/WM16/Y09-34 T G . . . . . C . . G . . G A . . . . . . . . . . G . . . T . 
SG/EHI/WM18/Y09-24 T . . . T C A C C G G . G . . . . C . . . . . . . G . . . T . 
SG/EHI/WM33/Y09-47 T G . . . . . C . . G . . G A . . . . . . . . . . G T G A T . 
SG/EHI/WM42/Y10-1 T . . . T C A C C G G . G . . . . C . . . . . . . . . . . . . 
SG/EHI/WM44/Y10-3 T . . . T C A C C G G . G . A . . C . A A C . . A . T G A T . 
SG/EHI/WM44/Y10-30 T . . . T C A C T G G . G . A . . C . A A C . . A . T G A T . 
               




Table 4.7: Percentage divergence of the non-repeat regions of the P. cynomolgi clones 
calculated with the Kimura-2 parameter, using transitions and transversions.  
 
Strain/ clone 1 2 3 4 5 6 7 8 9 10 11 
1 P. cynomolgi, Ceylon  *** - - - - - - - - - - 
2 P. cynomolgi, Berok  4.5 *** - - - - - - - - - 
3 SG/EHI/WM02/Y07-110 2.7 3.1 *** - - - - - - - - 
4 SG/EHI/WM05/Y09 -65 4.3 4.3 2 *** - - - - - - - 
5 SG/EHI/WM16/Y09-2 2 4.3 2.5 4.1 *** - - - - - - 
6 SG/EHI/WM16/Y09-34 1.8 4.1 2.2 3.8 0.2 *** - - - - - 
7 SG/EHI/WM18/Y09-24 2.7 3.1 0 2 2.5 2.2 *** - - - - 
8 SG/EHI/WM33/Y09-47 2.5 4.3 2.9 3.1 0.9 0.7 2.9 *** - - - 
9 SG/EHI/WM42/Y10-1 2.2 3.6 0.4 2 2.9 2.7 0.4 3.4 *** - - 
10 SG/EHI/WM44/Y10-3 4.3 4.3 2 0 4.1 3.8 2 3.1 2 *** - 
11 SG/EHI/WM44/Y10-30 4.3 4.5 2.2 0.2 4.1 3.8 2 3.1 2.2 2 *** 














4.3.3.3 P. fieldi transformants 
The non-repeat regions of the csp gene from Singapore isolates were aligned and 
compared with P. fieldi reference strain obtained from CDC (Table 4.8). Single 
genotype was observed for each of the monkeys infected with P. fieldi.  Comparison 
of P. fieldi isolated from Singapore monkeys with the reference strain showed seven 
polymorphic sites. Four of the polymorphic sites were synonymous while the other 
three were non-synonymous mutations. Unique haplotype AACCGG (at position 21, 
92, 110, 222, 311 and 432) were detected in SG/EHI/WM01/Y07 and 
SG/EHI/WM05/Y09 that were caught in 2007 and 2009, respectively. 
SG/EHI/WM15/Y09 and SG/EHI/WM18/Y09, both caught in 2009, had identical 
genotype with a unique nucleotide at position 93 (A), 222 (C) and 432 (G). On the 
other hand, there were only two polymorphic sites found in SG/EHI/WM44/Y10-64 at 
nucleotide positions 222 (C) and 432 (G). The pair-wise divergence between different 
transformants of P. fieldi obtained from Singapore long-tailed macaques ranged from 









Table 4.8: Gene polymorphisms based on the 456 nucleotide residues encoding the 
non-repeat region of the csp gene of P. fieldi malaria parasites obtained from 
Singapore’s long-tailed macaques (in bold). Nucleotide positions are numbered 
vertically above the polymorphic sites. Dots indicate identical nucleotide residues. 
High-lighted areas denote non-synonymous mutations.  
 
  Nucleotide position 
      1 2 3 4 
Strain/ clone 2 9 9 1 2 1 3 
1 2 3 0 2 1 2 
P. fieldi (CDC) G C C T T A A 
SG/EHI/WM01/Y07-23 A A . C C G G 
SG/EHI/WM05/Y09-68 A A . C C G G 
SG/EHI/WM15/Y09-163 . . A . C . G 
SG/EHI/WM18/Y09-92 . . A . C . G 
SG/EHI/WM44/Y10-64 . . C . G 
 
 
Table 4.9: Percentage divergence of the non-repeat regions of the P. fieldi clones 
calculated with the Kimura-2 parameter, using transitions and transversions.  
Strain/ clone 1 2 3 4 5 6 
1 P.fieldi (CDC) *** - - - - - 
2 SG/EHI/WM01/Y07-23 1.3 *** - - - - 
3 SG/EHI/WM05/Y09-68 1.3 0 *** - - - 
4 SG/EHI/WM15/Y09-163 0.7 1.1 1.1 *** - - 
5 SG/EHI/WM18/Y09-92 0.7 1.1 1.1 0 *** - 









4.3.3.4 P. inui transformants 
Alignment of the non-repeat regions of P. inui csp gene sequence between 
transformants derived from SG/EHI/WM91/Y11 and P. inui obtained from CDC 
revealed a total of 29 polymorphic sites where 10 synonymous and 19 non-
synonymous mutations were detected. When transformant SG/EHI/WM91/Y11-75 
was compared to the CDC reference strain, there were only seven polymorphic sites 
and pair-wise sequence divergence of 1.6% (Table 4.10 and 4.11).  However, when 
transformant SG/EHI/WM91/Y11-84 were compared to the CDC reference strain, 
there were 26 polymorphic sites and pair-wise sequence divergence was 5.9%.  On 
the other hand, when SG/EHI/WM91/Y11-84 was compared to P. inui isolated from 
East Malaysia (GU002523), there were only 18 polymorphic sites observed with a 
pair-wise sequence divergence of 4.8%. In contrast, there were 33 polymorphic sites 
and a pair-wise sequence divergence of 7.6% when SG/EHI/WM91/Y11-75 was 








Table 4.10: Gene polymorphisms based on the 456 nucleotide residues encoding the non-repeat region of the csp gene of P. inui malaria 
parasites obtained from Singapore’s long-tailed macaques (in bold). Nucleotide positions are numbered vertically above the polymorphic sites. 
Dots indicate identical nucleotide residues. Highlighted areas denote non-synonymous mutations.  
  Nucleotide position 
Strain/ clone 
      1 1 1 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 4 4 4 4 4 
1 4 5 7 8 9 0 4 4 5 6 7 7 7 9 9 0 2 3 3 3 4 6 7 8 8 8 1 1 4 4 5 5 5 7 1 2 3 3 3 
8 8 1 3 5 0 4 5 7 3 7 1 5 7 3 5 3 8 0 6 8 2 3 5 2 3 4 0 8 3 4 2 8 9 8 1 6 3 5 9 
P. inui (CDC) C C A G T A A G C G C C G C G C A G A A T A T G A C A A T C T C G T G T A C A C 
P. inui (GU002523) T A G A . G G . A C T . A T T . C C . G C C C C . A C . A A C G A C T C C T . A 
SG/EHI/WM91/Y11-75 . . . A . G . . . . . . . . A A . C G . . . . . . . . G . . . . . . . . . . . . 
SG/EHI/WM91/Y11-84 . . . A A G . C . . A A . . A . C C . . C C C C G A C G A . C . . C T C C T G A 
                                          
                    
 
Table 4.11: Percentage divergence of the non-repeat regions of the P. inui clones calculated with the Kimura-2 parameter, using transitions and 
transversions.  
Strain/ clone 1 2 3 4 
1 P. inui (CDC) *** - - - 
2 P. inui (GU002523) 7.6 *** - - 
3 SG/EHI/WM91/Y11-75 1.6 7.6 *** - 
4 SG/EHI/WM91/Y11-84 5.9 4.8 5.2 *** 
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4.3.4 Polymorphisms within the Region I, Region II-plus and the central 
tandem repeat region of the Plasmodium species csp gene 
4.3.4.1 P. knowlesi transformants 
The region I of the csp genes (based on the short amino acid motif KLKQP), were 
found to be conserved in all P. knowlesi transformants obtained in this study (Table 
4.12). The nucleotide sequence of region II-plus was also found to be conserved 
among all human and monkey samples, except at position 18, which was substituted 
with either arginine (R) or lysine (K) (Table 4.12). The central repeat regions of P. 
knowlesi transformants were highly variable with size ranging from 81 bp to 657 bp, 
and can be categorized into amino acid consensus groupings (Table 4.13). 
Plasmodium knowlesi transformants isolated from local human cases included the 
following amino acid groupings N(A/E)GQPQAQGD(G/R)A (H7-1), 
EQPA(A/P)(G/A)(A/P)(G/R)(G/R/A) (H1-15 and H2-12) and 
E(E/Q)PAPG(R/G)E(Q/E)PAP(G/A)(R/P) (H24-10). Interestingly, several 
transformants isolated from monkeys also showed similar amino acid motif 
groupings. To date, the amino acid motifs, (Q/E)GNGGAGQAQP and 
EGNREAPAQP were only found in monkeys. In contrast, the amino acid motifs 
(NAEGGAN(A/V)(G/R)QP and NAGGANAGQP) deduced from the two imported 
human cases were unique and not found among P. knowlesi transformants isolated 






Table 4.12: Comparison of amino acid sequences in the region I and region II-plus of 
the P. knowlesi H and Nuri strain, and isolates from the human and macaque samples. 
Dots represent identical amino acid and those underlined indicate substituted residue. 
Strain/ clone   Region I   Region II-plus 
          
P. knowlesi H  KLKQP EWTPCSVTCGNGVRIRRK 
P. knowlesi Nuri  .  . .  . .  .  .  . .  . . .  .  . .  .  .  . . . .  . .  
SG/EHI/H1/Y07 - 15 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/H2/Y07 - 12 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/H7/Y07 - 1 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  .  . 
SG/EHI/H24/Y08 - 10 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  .  . 
SG/EHI/H1-im/Y09-17/18//80/95/100 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/H2-im/Y09-3/7/11/12/18 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM01/Y07 - 6 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  .  . 
SG/EHI/WM02/Y07 - 1 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM02/Y07 - 39 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM04/Y09-3/6/8/9/12/13/14/15 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM05/Y09 - 70 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  .  . 
SG/EHI/WM05/Y09 - 79 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM11/Y09 - 74 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM15/Y09 - 149 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM16/Y09 - 85 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM17/Y09 - 4/18/30 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  .  . 
SG/EHI/WM26/Y09 - 1/13/47/98/123 
 .  . .  . .  .  .  . .  . . .  .  . .  .  .  . . . .  .  . 
SG/EHI/WM26 /Y09- 60 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM33 /Y09- 39 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM35/Y09 - 38/74 
 .  . .  . . .  .  . .  . . .  .  . .  .  .  . . . .  . . R 
SG/EHI/WM91/Y11 - 24 









Table 4.13: Comparison of amino acid motifs and the sequence size of the tandem 
repeat region and full csp gene for P. knowlesi H and Nuri strain, and isolates from 
human and macaque samples 
Isolate/ clone/ 
strain 
Amino acid motifs of 
tandem repeat region 














      
P. knowlesi H 
NEGQPQAQGDGA (A) 1 
ABBBBBBBBBBB 432 1092 
NAGQPQAQGDGA (B) 11 
      
P. knowlesi 
Nuri  
EQPAAGAGG (C) 11 
CCCDCCCCCDCCD
CE 405 1056 EQPAAGARG (D) 3 
EQPAPAPRR (E) 1 
      
H1-15*, H2-
12*, WM11-
74*, WM26 - 
60, WM33 -
39*, WM35 -
38, WM35 - 
74* 
EQPAAGAGG (C) 12 
CCCCCCCCCCCEC
EF 405 1026 
EQPAPAPRR (E) 2 
EQPAPGAGA (F) 1 
      
H7-1 
NEGQPQAQGDGA (G) 1 
GHHHHHHHHHIH 432 1092 NAGQPQAQGDGA (H) 10 
NAGQPQAQGDRA (I) 1 
      
H24-10*, WM5 




WM26 - 13*, 
WM26 - 47, 
WM26 - 123 
EEPAPGREQPAPGR (J) 4 
JJJJKKLMN 378 1020 
EQPAPGREEPAPGR (K) 2 
EQPAPGREQPAPGR (L) 1 
EQPAPGGEQPAPGR (M) 1 
EQPAPGGEQPAPAP (N) 1 







NAEGGANAGQP (O) 10 
OOOPOOQQOOOQ
OOQ 492 1278 
NAGGANAGQP (P) 1 
NAEGGANARQP (Q) 4 
      
H1-im-80 
NAEGGANAGQP (O) 4 
OOQOOQ 198 951 
NAEGGANARQP (Q) 2 
      
H1-im-95 
NAEGGANAGQP (O) 9 
OOOPORQQOOOQ
OOQ 492 1242 
NAGGANAGQP (P) 1 
NAEGGANVGQP ( R) 1 
NAEGGANARQP (Q) 4 





Table 4.13 continued 
Strain/ clone 
Amino acid motifs of 
tandem repeat region 















NAEGGANAGQP (O) 14 
OOOPOOQQOOOQ
OOOOQOOQ 657 1443 NAGGANAGQP (P) 1 
NAEGGANARQP (Q) 5 
      
WM04 - 3 
QGNGGAGQAQP (S) 6 
STTSSSSS 264 879 
EGNGGAGQAQP (T) 2 
     
 
WM04 - 6*, 
WM04-12*, 
WM04 - 13, 
WM04 - 14, 
WM16-85*, 
WM15 - 149 












EGNGGAGQAQP (T) 9 
EGNREAPAQP (U) 1 
      
WM04 - 8 
QGNGGAGQAQP (S) 3 
SSUS 129 744 
EGNREAPAQP (U) 1 
      
WM04 - 9 
QGNGGAGQAQP (S) 2 
STTTTTTTTTTS 462 1077 
EGNGGAGQAQP (T) 12 
      
WM04-15 
QGNGGAGQAQP (S) 7 
STTTTTTTSSSSTSU
S 525 1140 EGNGGAGQAQP (T) 8 
EGNREAPAQP (U) 1 
      
WM05-79 
EQPAAGAGG (C) 1 
CEF 81 702 EQPAPAPRR (E) 1 
EQPAPGAGA (F) 1 
      
WM26 - 98 
EEPAPGREQPAPGR (J) 4 
JJJJKV 252 894 EQPAPGREEPAPGR (K) 1 
EQPAPGREEPAPAP (V) 1 
      
* Identical csp non-repeat sequences (within same group) 






4.3.4.2 P. cynomolgi transformants 
The region I and region II-plus of P. cynomolgi transformants derived from all 
monkey isolates were found to be identical with the exception of SG/EHI/WM16/09-2 
and SG/EHI/WM44/10-3/30 (Table 4.14).  The region I was based on the short amino 
acid motif KLKQP, while region II-plus was based on EWSPCSVTCGKGVRMRRK.  
In SG/EHI/WM16/09-2, position five of the region II-plus was substituted with a 
tyrosine (Y) instead of cysteine (C), while in SG/EHI/WM44/10-3/30, the position 17 
of the region II-plus was substituted with a lysine (K) instead of arginine (R). The 
central repeat regions of P. cynomolgi transformants were found to be variable, with 
sizes ranging from 369 bp to 585 bp and composed of the following amino acid motif 
sequences: DGNNAA, DGGVQPPA(G/A)GGN(N/R)A, PAAADGA, PAAGGN, 
QAG(A/G)Q(A/P)G(G/A)(G/N)(N/A), QAGGDAGNA, QAGGA, AAANAGDGQP, 
AANAGGA and QAAGGA (Table 4.15). The complete csp gene sequences of 
transformants were identical between SG/EHI/WM02/Y07-110 and 
SG/EHI/WM18/Y09-24, and between SG/EHI/WM05/Y09-65 and 












Table 4.14: Comparison of amino acid sequences in the region I and region II-plus of 
the P. cynomolgi Ceylon and Berok strain, and isolates from the macaque samples. 
Dots represent identical amino acid and those underlined indicate substituted residue. 
 
Strain/clone   Region I Region II-plus 
    
P. cynomolgi Ceylon KLKQP EWSPCSVTCGKGVRMRRK 
P. cynomolgi Berok   . .  .  . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 
SG/EHI/WM02/Y07 - 110   . .  .  . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 
SG/EHI/WM05/Y09 - 65   . .  .  . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 
SG/EHI/WM16/Y09 - 2   . .  .  . .  .  .  . . Y.  .  .  . .  .  .  .  .  .  .  . . 
SG/EHI/WM16/Y09 - 34   . .  .  . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 
SG/EHI/WM18/Y09 - 24   . .  .  . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 
SG/EHI/WM33/Y09  - 47   . .  .  . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 
SG/EHI/WM42/Y10 - 1   . .  .  . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 













Table 4.15: Comparison of amino acid motifs and the sequence size of the tandem 
repeat region and full csp gene for P. cynomolgi Ceylon and Berok strain, and isolates 
from macaque samples 
 
Isolate/ clone/ strain 
Amino acid motifs of 
tandem reoeat region 
(single alphabet code 














P. cynomolgi Ceylon 
AGNNAAAGE (A) 13 
AAAAAABABAC
ABABBADADAE 585 1197 
AGNNAAGGA(B) 5 
AGNNAAGGE ( C) 1 
AGAGGAGR (D) 2 
AGAGGAGG (E) 1 
P. cynomolgi Berok 
PAGDGA (F) 1 
FGHHHHHHHHH
HIJKJKJJLM 537 1137 
PEGDGA (G) 1 
PAAPAGDGA (H) 10 
PAGNR (I) 1 
AGGQPAAGGNQ (J) 3 
AGGNR (K) 2 
AGAQAGGNQ (L) 1 
AGAQAGGAN (M) 1 
SG/EHI/WM2/Y07 - 110*, 
 SG/EHI/WM18/Y09 -24* 
DGNNAA (N) 1 
NOOOOOOOOOO
P 510 1128 
DGGVQPPAGGGNNA
A (O) 10 
DGGVQPPAAGGNRA 
(P) 1 
SG/EHI/WM5/Y09 - 65*, 
SG/EHI/WM44/Y10 - 3*, 
30 
PAAADGA (Q) 10 
QQQQQQQQQQR
SSSTTTSU 492 1095 
PAAGGN (R ) 1 
QAGAQAGAGGN (S) 4 
QAGGQPGAGGN (T) 3 
QAGGQAGGANA (U) 1 
SG/EHI/WM16/Y09 - 2, 34 




540 1158 QAGGA (W) 18 
SG/EHI/WM33/Y09-47 




525 1143 QAGGA (W) 17 
SG/EHI/WM42/Y10-1 
AAANAGDGQP (X) 10 
XXXXXXXXXXY
Zaa 369 978 
AANAGGA (Y) 1 
QAAGGA (Z) 1 
QAGGA (a) 2 





     




4.3.4.3 P. fieldi transformants 
The region I and region II-plus of P. fieldi transformants derived from all monkey 
isolates were identical. These regions were based on the short amino acid motif 
KLKQP and EWTPCSVTCGNGVRLRRK, respectively (Table 4.16). The central 
repeat regions of P. fieldi transformants were variable with size ranging from  396 bp 
to 561 bp and composed of the following amino acid motif sequences:  
PGANQ(E/G)G(G/A)(A/K)(A/P)A and (A/G)(N/G)(D/G)AGQNQP (Table 4.17).   
The complete csp gene sequences of transformants were identical between 
SG/EHI/WM01/Y07-23 and SG/EHI/WM05/Y09-68, and between 














Table 4.16: Comparison of amino acid sequences in the region I and region II-plus of 
the P. fieldi from CDC, and isolates from the macaque samples. Dots represent 
identical amino acid. 
          
Strain/clone Region I Region II-plus 
          
P. fieldi (CDC) KLKQP EWTPCSVTCGKGVRVRRK 
SG/EHI/WM01/Y07- 23  . .  .   . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 
SG/EHI/WM05/Y09 - 68  . .  .   . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 
SG/EHI/WM15 Y09- 163  . .  .   . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 
SG/EHI/WM18 Y09 - 92  . .  .   . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 




Table 4.17: Comparison of amino acid motifs and the sequence size of the tandem 
repeat region and full csp gene for P. fieldi (CDC), and isolates from macaque 
samples 
Isolate/ clone/ strain 
Amino acid motifs of 
tandem repeat region 















P. fieldi (CDC), 
SG/EHI/WM15/Y09-163, 
SG/EHI/WM44/Y10-64 
PGANQEGGAAA (A) 13 
AAAAAAAAAAA
ABBBAC 561 1149 PGANQGGGAAA (B) 3 
PGANQGGAKPA (C) 1 
      
SG/EHI/WM1/Y07-23*, 
SG/EHI/WM5/Y09-68* 
ANDAGQNQP (D) 13 DDDDDDDDDDD
DDEEEEEE 513 1131 GGGAGQNQP (E) 6 
      
SG/EHI/WM18/Y09-92 
PGANQEGGAAA (A) 9 
AAAAAAAABBA
C 396 984 PGANQGGGAAA (B) 2 
PGANQGGAKPA (C) 1 
      





4.3.4.4 P. inui transformants 
The region I of P. inui is based on the amino acid motif NLKQP instead of the usual 
KLKQP found in P. knowlesi, P. cynomolgi and P. fieldi. The region II-plus of 
transformant SG/EHI/WM91/Y11-61 was identical to the CDC reference strain, while 
SG/EHI/WM91/Y11-73’s region II-plus was identical to that of P. inui isolated from 
East Malaysia (Table 4.18). The size of the central repeat region and the amino acid 
motif sequences of both transformants varied from each other.  SG/EHI/WM91/Y11-
61 had a central repeat region of 420bp, with amino acid motif 
A(G/Q)(D/G/N/K)P(A/G)(P/G)(P/Q), while SG/EHI/WM91/Y11-73’s central repeat 
region was  540 bp long, with the amino acid motif 














Table 4.18: Comparison of amino acid sequences in the region I and region II-plus of 
the P. fieldi from CDC and East Malaysia, and isolates from the macaque samples. 
Dots represent identical amino acid and those underlined indicate substituted residue. 
 
          
Strain/clone Region I Region II-plus 
          
P. inui (CDC) NLKQP EWSVCSVSCGQGVRVRRK 
P. inui (GU002523)  . .  .   . .    .  .  . A . .  .T  . .  T .  . .  . .  . .  
WM91 - 61  . .  .   . .  .  .  . .  . .  .  .  . .  .  .  .  .  .  .  . . 
WM91 - 73    . .  .   . .    .  .  . A . .  .T  . .  T .  . .  . .  . .  
 
 
Table 4.19: Comparison of amino acid motifs and the sequence size of the tandem 
repeat region and full csp gene for P. inui (CDC), and isolates from macaque samples 
Strain/ clone 
Amino acid motifs of 
tandem reoeat 
region (single 















P. inui (CDC) 
AQDPGAP (A) 1 
ABBBBBCBBBCBCBD
DE 375 1056 
GQDPGAP (B) 10 
GQAPGAP (C ) 3 
GQDPAAP (D) 2 
ARDPAAP (E) 1 
      
SG/EHI/WM91/Y11-61 
AGDPAPP (F) 14 
FFFFFFFFFFFFFFGHH
HII 420 1014 
AGGPAGQ (G) 1 
AQNPGGP (H) 3 
AQKPGGP (I) 2 













The csp gene is a single copy gene which encodes for the highly antigenic surface 
protein of the sporozoite [96, 105]. Its polymorphism can be observed through cloning 
and sequencing of the gene isolate. Gene polymorphism can be presented as sequence 
variation in the conserved non-repeat N- and C- terminal of the csp gene, or a 
difference in the pattern and length of the tandem amino acid motif repeats.  
 
Phylogenetic inferences based on the non-repeat region of csp gene from the 
Plasmodium species isolates of 15 infected wild long-tailed macaques confirmed the 
presence of four species of simian malaria parasites (P. knowlesi, P. cynomolgi, P. 
fieldi and P. inui). These were in accordance to the respective macaques’ nested PCR 
screening results, with the exception of macaque SG/EHIWM59/Y10 and 
SG/EHI/WM91/Y11. Nested PCR assay detected P. coatneyi in SG/EHI/WM59/Y10 
and P. knowlesi in SG/EHI/WM91/Y11. However, transformants containing csp gene 
of these two simian Plasmodium species were not isolated from the respective 
samples. This could be due to the low parasite load of these parasite species in these 
macaques. As such, their detection was only revealed by the highly sensitive nested 
PCR assay. 
 
Characterization of the csp gene not only confirmed the nested PCR assay’s results, 
but also revealed the high genotypic diversity of the simian malaria parasites, 
especially P. knowlesi (Table 4.20). Four distinct subclades were observed within the 




Table 4.20: Comparison of the species of malaria parasites from the 15 wild 
macaques, identified by nested PCR assay and csp gene characterization 
Monkey isolate Age  Malaria parasites identified by: 
 
Nested PCR 
Csp gene sequencing  
(no. genotypes) 
SG/EHI/WM01/Y07 Adult Pk, Pfi Pk (1), Pfi (1) 
SG/EHI/WM02/Y07 Adult Pk, Pcy Pk (2), Pcy (1) 
SG/EHI/WM04/Y09 Adult Pk Pk (6) 
SG/EHI/WM05/Y09 Adult Pk, Pcy, Pfi Pk (2), Pcy (1), Pfi (1) 
SG/EHI/WM11/Y09 Juvenile Pk Pk (1) 
SG/EHI/WM15/Y09 Juvenile Pk, Pfi, Pct Pk (1), Pfi (1) 
SG/EHI/WM16/Y09 Adult Pk, Pcy Pk (1), Pcy (2) 
SG/EHI/WM17/Y09 Juvenile Pk Pk (3) 
SG/EHI/WM18/Y09 Juvenile Pcy, Pfi Pcy (1), Pfi (1) 
SG/EHI/WM26/Y09 Adult Pk Pk (6) 
SG/EHI/WM33/Y09 Adult Pk, Pcy Pk (1), Pcy (1) 
SG/EHI/WM35/Y09 Juvenile Pk Pk (2) 
SG/EHI/WM42/Y10 Adult Pcy Pcy (1) 
SG/EHI/WM44/Y10 Adult Pcy, Pfi Pcy (2), Pfi (1) 
SG/EHI/WM91/Y11 Adult Pk, Pin  Pin (2) 
 
 
Pct, Pcy, Pfi, Pin and Pk denodes Plasmodium coatneyi, P. cynomolgi, P. fieldi, P. 











were six macaques infected with multiple genotypes of P. knowlesi. Of these, two had 
six genotypes; one had three genotypes, while the rest had two genotypes each. The 
high prevalence of P. knowlesi, together with the multiple genotypes and species 
infections in both adult and juvenile macaques, reflects a high malaria transmission 
intensity among these macaques in the forest. In a study conducted by Arez and co-
workers in Antula, Republic of Guinea Bissau; an area with intense falciparium 
transmission, the mosquito vector An. gambiae was found to acquire one to two 
genotypes of P. falciparium, while multiple-genotype infections were common in the 
human population. The asynchronous gametocyte production of different genotypes 
of malaria parasites resulted in the low number of genotypes in the vector hosts, even 
though the vertebrate hosts were infected with more than one genotypes of the 
parasite. Hence, for a vertebrate host to acquire multiple genotypes of the parasites, 
the host will have to receive multiple infective bites from several individual 
mosquitoes harbouring different genotypes. Therefore, the presence of multiple 
species and genotypes infection in the vertebrate hosts indicates the presence of high 
malaria transmission intensity [124].  
 
As discussed in previous chapter, the high malaria infection rate (80%) observed 
among juvenile macaques might be a result of an intense malaria transmission in the 
area, or the occurrence of vertical transmission of simian malaria parasites. Cases of 
congenital malaria had been reported for P. vivax and P. falciparium [125], although 
it is not yet known if the five simian malaria parasites can cross the placental barrier. 
Nonetheless, seven out of 20 of the malaria-positive juvenile macaques were infected 
with more than one species of Plasmodium parasites (Table 3.1). In addition, two of 
the knowlesi-infected juvenile macaques which were randomly selected for the 
113 
 
Plasmodium csp gene characterization were found to harbour multiple P. knowlesi 
genotypes (Table 4.20). These observations too suggest the presence of a high malaria 
transmission intensity in the restricted-access forest.   
 
In contrast to the high genotypic diversity of parasites detected in the wild macaques, 
all the locally-acquired human knowlesi cases were each infected with single 
knowlesi genotype. This might be due to a lower exposure to mosquito bites for 
humans as compared to the simian hosts, indicating that the vector responsible for the 
simian malaria transmission in Singapore may be highly simiophagic (attracted to 
monkey hosts for blood meal). In an entomological surveillance conducted by the 
Singapore military in the affected forest, at least 6 species of anopheline mosquitoes 
were caught through human landing catch. These include An. barbirostris sp. group, 
An. sinensis, An. tesselatus, An. sundaicus, An. lesteri, and An. kochi [20]. Majority of 
these mosquitoes caught were known to be anthropohilic [126] . Of the three thousand 
mosquitoes screened by PCR, none was tested positive for malaria parasites (EHI 
unpublished data), suggesting that these anopheline mosquitoes caught may not be 
involved in the sylvatic transmission cycle of simian malaria parasites. Humans are 
their accidental hosts and the risk of acquiring knowlesi infection is probably only 
highest when they enter the forest. This could explain the low number of human 
knowlesi cases reported in Singapore despite thousands of military personnel 
accessing the affected forest area.  
 
The genotypes found in the four local human cases were shared with five of the 
macaques, some of which were caught at different time points. The identical csp 
sequences between macaques and human cases suggested a strong molecular 
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epidemiological linkage between the two. SG/EHI/H01/Y07 and SG/EHI/H02/Y07, 
the first two human knowlesi cases reported in 2007, had identical csp gene sequences 
with P. knowlesi isolates from SG/EHI/WM02/Y07. Similarly, the third human 
knowlesi case in 2007 (SG/EHI/H07/Y07) had shared csp gene sequences with the 
two macaques caught in the same year (SG/EHI/WM01/Y07 and 
SG/EHI/WM02/Y07). Both macaques were trapped in the restricted access forest 
upon the notification of the human knowlesi cases. These suggested that the wild 
long-tailed macaques were reservoir hosts of P. knowlesi and the human cases might 
have acquired the infection in the same vicinity where the infected macaques were 
found. Interestingly, identical P. knowlesi csp gene sequences in two of the human 
cases (SG/EHI/H01/Y07 and SG/EHI/H02/Y07) were also detected in macaques 
sampled two years later (SG/EHI/WM11/Y09, SG/EHI/WM33/Y09, 
SG/EHI/WM35/Y09). The detection of identical P. knowlesi csp gene sequences in 
macaques caught across different years may suggest an ongoing sylvatic transmission 
of simian malaria parasites among the wild macaques.  
 
Unlike the locally-acquired knowlesi cases, the two imported human knowlesi cases 
(SG/EHI/H1-im/Y09 and SG/EHI/H2-im/Y09), had strikingly higher number of P. 
knowlesi genotypes. These two patients had contracted the infection after visiting 
Pahang, a state in peninsular Malaysia with reports of P. knowlesi trasmission [24]. 
Each patient sample had at least five distinct genotypes, indicating that these patients 
might have acquired their infection from an area with intense P. knowlesi 
transmission. This conclusion is drawn with reference to the observations made by 
Arez and co-workers; the high genetic diversity of the parasites in humans is likely a 
result of superinfection in an area with intense malaria transmission [124]. As the csp 
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gene sequences of P. knowlesi isolates from these two cases were distinct from the P. 
knowlesi isolates of our local cases and macaques, csp gene characterization may be 
potentially useful in the differentiatiation of imported P. knowlesi cases from the 
locally-acquired infections. 
 
Sequence alignment of the csp non-repeat region of the P. inui isolates from 
SG/EHI/WM91/Y11 revealed two sub-variants of P. inui, as demonstrated by the high 
pair-wise divergence rate of 7.6% and amino acid polymorphisms at the conserved 
region I and region II-plus (Table 4.18 and 4.19). One of the sub-variant was similar 
to the isolate from CDC while the other was closer to the P. inui isolate from Kapit, 
Sarawak. The high pair-wise divergence rate may suggest the presence of a sub-
variant of P. inui or possibly a novel species of malaria parasite that is closely related 
to P. inui.  However, a second gene needs to be sequenced to lend further support to 
this finding. 
 
In conclusion, analyses based on the csp genes of Plasmodium isolates from the 
human and macaque samples revealed that knowlesi malaria is a zoonosis in 
Singapore and the wild macaques are also reservoir hosts for a panel of simian 
malaria parasites. The high diversity of simian malaria parasites found in local 
macaques strongly suggests an intense and continuous sylvatic malaria transmission 
among the wild macaques. Unfortunately, the vector responsible for this transmission 





SUMMARY AND INDICATIONS FOR FUTURE WORK 
5.1 Summary 
Natural infection of simian malaria in man was once considered to be rare and of no 
public health significance, until the discovery of a large focus of human knowlesi 
cases in Kapit Division of Sarawak, Malaysian Borneo in 2004 [45]. With the 
knowledge of this zoonotic transmission and its clinical manifestations, coupled with 
the advent of molecular assays for its detection, human knowlesi cases were first 
reported in Singapore in 2007 [46]. This prompted an epidemiological investigation 
that led to the identification of long-tailed macaques as the reservoir of infection.  
Furthermore, only macaques found in the restricted forest were infected with P. 
knowlesi.  This suggests that transmission of P. knowlesi might be occurring in the 
forest and not in urbanized areas [20]. Aside from P. knowlesi, long-tailed macaques 
are also natural host to other species of malaria parasites, of which P. cynomolgi and 
P. inui are potentially infectious to humans [7]. In order to evaluate the risk of 
zoonotic malaria transmission in Singapore, this study was undertaken to determine 
the prevalence and genetic diversity of simian malaria parasites in local macaques. 
 
Microscopic observation of the giemsa-stained blood film for the detection and 
identification of simian malaria parasites can be difficult and inaccurate due to the 
overlapping morphological characteristics between different simian Plasmodium 
species. Morphological identification is further complicated in macaques hosts with 
mixed infection and low parasitemia [1, 7]. Therefore, a sensitive screening assay for 
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Plasmodium parasites and a species-specific nested PCR assay to identify the five 
different species of simian malaria parasite were developed.  
 
The Plasmodium-genus specific PCR assay developed in this study was highly 
specific and sensitive for malaria parasites. Its single amplification reaction reduces 
the chance of PCR product cross contamination, a common problem associated with 
the nested PCR assay. In addition, its short run-time and compatibility for use in both 
conventional and real-time PCR format makes it useful for the screening of malaria 
parasites in large number of samples, and allow laboratories with different resources 
to have comparable results. The simian malaria-species specific assay designed in this 
study was found to be specific to the five simian malaria species, making it a valuable 
tool for the prevalence study of simian malaria parasites in macaques. As the 
published knowlesi-specific PCR primers have shown random cross-reaction with P. 
vivax [90], it has limited use in areas where these two parasites co-exist. Therefore, 
the simian malaria-species specific assay designed in this study can also aid in the 
confirmation of zoonotic transmission of P. knowlesi, and possibly P. cynomolgi and 
P. inui in humans.  
 
A total of 157 local long-tailed macaques were screened using the PCR assays 
developed in this study. Of these, 92 macaques were caught in the restricted-access 
forests, while 65 were caught from areas near to human habitations. Among the 
macaques caught in the forest, 71.7% were found to harbour malaria parasites while 
none of the peri-domestic macaques were infected. The difference in the infection rate 
among macaques caught from different geographical locations could be due to the 
lack of competent vectors for simian malaria transmission in the urban areas. Using 
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the simian malaria species-specific nested PCR assay, all five simian Plasmodium 
species (namely P. knowlesi, P. coatneyi, P. cynomolgi, P. fieldi and P. inui), which 
long-tailed macaques are known natural host, were identified. Plasmodium knowlesi 
(68.2%) was the most predominant malaria parasites found, followed by P. cynomolgi 
(60.6%), P. fieldi (16.7%), P. coatneyi (3.0%) and P. inui (1.5%).  All of these 
malaria parasites, except P. inui, were found in wild macaques caught from mainland 
Singapore, while P. knowlesi and P. inui were detected in the sole malaria-positive 
macaque collected from the forest of an offshore military island.  
 
The high infection rate of macaques, particularly among the juvenile macaques, might 
be a result of an intense malaria transmission in the restricted forest. Although we 
cannot negate the possibility of a vertical transmission of simian malaria parasites 
from the infected mothers to the juveniles, the co-infection of multiple Plasmodium 
species and genotypes among the infected macaques is also a reflection of an intense 
malaria transmission in the forest. In addition, the sylvatic transmission of simian 
malaria parasites among local macaques must have been ongoing in Singapore as P. 
knowlesi was first discovered in a Singapore macaque in 1931 [14, 87]. The detection 
of identical P. knowlesi csp gene sequences from macaques trapped across different 
years (2007-2009) further accentuates this observation.  
 
Molecular characterization and phylogentic analyses of the Plasmodium csp gene 
obtained from Singapore isolates revealed that P. knowlesi found in local human cases 
were identical to those found in some macaques. This clearly illustrates that four of 
the human knowlesi cases were acquired locally and the transmission was zoonotic.  
In contrast to the majority of the macaques which were infected with multiple P. 
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knowlesi genotypes, only single genotype was found in local human cases.  This may 
reflect a high intensity of transmission in the forest and the human cases had acquired 
the infection when they entered these forests.  On the contrary, the two human cases 
which contracted P. knowlesi infection after visiting Pahang, peninsular Malaysia, 
harboured multiple knowlesi genotypes. These genotypes were distinct when 
compared to the local isolates. These findings, together with other epidemiological 
data, strongly confirmed that these P. knowlesi infections were not acquired locally. 
 
5.2 Indications for future research 
Despite the high intensity and ongoing transmission of malaria parasites among the 
wild macaques, the vectors involved in the sylvatic transmission of zoonotic knowlesi 
in Singapore have yet to be identified. To date, only mosquitoes from the Anopheles 
leucosphyrus group have been incriminated as vectors of P. knowlesi and other simian 
malaria parasites. These include An. hackeri [127] and An. cracens [24] in peninsular 
Malaysia, An. latens in Sarawak, East Malaysia [128, 129] and An. dirus in Vietnam 
[130, 131]. Although Singapore lies within the distribution limit of the An. 
leucosphyrus group [12], there has been no records of the presence of these species 
group of mosquitoes [132]. Entomological surveillance conducted by the Singapore 
military in the affected forest also did not reveal the presence of the An. leucosphyrus 
group of mosquitoes. Instead, at least six species of human-biting anopheline species 
were found, but none of these mosquitoes collected was positive for malaria parasites. 
  
The vector for simian malaria transmission in Singapore is postulated to be highly 
attracted to monkey hosts instead of human, as inferred from the high intensity of 
transmission among the macaques and a contrasting low sporadic human knowlesi 
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incidence. Hence, future study that aims to elucidate the vector may require the use of 
monkey-baited traps [24, 128].   
 
The identity of the vector is important in ascertaining and mitigating the risk of 
zoonotic knowlesi transmission so that targeted vector control operations can be 
implemented. The efficiency of any vector in transmitting malaria in any given 
geographical area is largely due to their bionomics, which are major elements in 
determining the appropriateness of control measures to be initiated [133]. Since the 
notification of the first human knowlesi case, the Singapore Armed Forces has put 
into operation general mosquito control measures such as environmental management, 
insecticide-treated uniforms and the use of Bacilus thuringiensis var. Israelensis [20].  
These measures were implemented from 2007 to current, and have resulted in a 
reduction of total mosquito population from 64.1 mosquitoes per sampling site in 
August 2007 to 4.3 per site by June 2011 (Patrick Lam, personal communication, 14th 
November 2011). Despite the drop in mosquito population, the infection rate of wild 
macaques, particularly the juvenile macaques, remains high. Majority of these 
juvenile macaques (age three years and below) were sampled from 2009 to 2011. The 
high infection rate, along with the multiple species and genotypes infection among 
these juveniles, suggests that the current mosquito control measures may not be 
effective against the simiophagic vector responsible for simian malaria transmission 
among the macaques. The knowledge of the vector identity and its bionomics will 
allow the design of a targeted vector control strategy. Along with the available 
epidemiological and molecular data obtained from the human cases and macaque 
hosts, the vector identity and its associated entomological data will also provide a full 
epidemiological picture of P. knowlesi transmission in Singapore.  
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Apart from determining the vector responsible for the transmission, it may also be 
important to monitor the movement and home range of the wild macaques through 
global positioning system (GPS) tracking. This will determine the spatial distribution 
of these macaques, and consequently aid in the identification of risk areas for P. 
knowlesi transmission. Although peri-domesticated macaques in this study were found 
to be negative for malaria parasite, it is possible that wild macaques from the 
restricted-access forest may migrate to areas near human habitations due to 
deforestation and habitat destruction. On the other hand, there is also a possibility of 
simiophagic mosquito vector, migrating out with the monkeys to areas close to human 
habitations. This future changes in land use and exploitation of the forest may result 
in greater contact between monkeys, mosquitoes and humans, increasing the risk of 
zonnotic transmission of simian malaria parasites to the general population.  
Therefore, the elucidation of the vectors, together with the distribution and the 
dispersal of the wild macaques in the restricted forest area should be investigated for 
the identification of risk areas for P. knowlesi transmission. 
 
5.3 Conclusion 
This study has provided evidence to illustrate the presence of an intense and ongoing 
sylvatic transmission of malaria parasites among local macaques. However, this 
should not be a cause for alarm as the risk of the general population acquiring 
zoonotic malaria should be low, due to the absence of malaria parasite in peri-
domestic macaques. Moreover, all reported local cases thus far were associated with 
occupation or travel history. However, the risk of acquiring simian malaria in 
Singapore can be better demonstrated with information on the spatial distribution of 
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macaques and the identification of vectors involved in the transmission among 
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Appendix A: List of simian Plasmodium species controls and their source 
Species Source Date of bloodspot 
Plasmodium coatneyi Isolated from Anopheles 
hackeri 
22/02/2010 
Plasmodium cynomolgi B Propagated in rhesus 
monkey 
12/04/2001 
Plasmodium fieldi Isolated from Anopheles 
hackeri followed by 
Rhesus monkey 
24/04/2006 



































Appendix B: Binding sites of primers for simian Plasmodium species-specific PCR 









Appendix C: Details of peri-domestic long-tailed macaques  
 
Code Location Gender Age Date collected 
SG/EHI/PM01/Y08 
Central Nature Reserve 
Male Adult January 2008 
SG/EHI/PM02/Y08 Male Adult January 2008 
SG/EHI/PM03/Y08 Male Adult January 2008 
SG/EHI/PM04/Y08 Male Adult January 2008 
SG/EHI/PM05/Y08 Male Adult January 2008 
SG/EHI/PM06/Y08 Male Adult January 2008 
SG/EHI/PM07/Y08 Male Adult January 2008 
SG/EHI/PM08/Y08 Male Adult January 2008 
SG/EHI/PM09/Y08 Male Adult January 2008 
SG/EHI/PM10/Y08 Male Adult January 2008 
SG/EHI/PM11/Y10 Mandai Lake Road Male Adult 23/02/2010 
SG/EHI/PM12/Y10 Mandai Lake Road Male Adult 23/02/2010 
SG/EHI/PM13/Y10 Mayfair Park Male Adult 23/02/2010 
SG/EHI/PM14/Y10 Singapore Island Country Club Male Adult 23/02/2010 
SG/EHI/PM15/Y10 Bukit Manis Road Male Adult 23/02/2010 
SG/EHI/PM16/Y10 Windsor Park Male Adult 03/03/2010 
SG/EHI/PM17/Y10 Windsor Park Male Adult 03/03/2010 
SG/EHI/PM18/Y10 Venus Drive Male Juvenile 03/03/2010 
SG/EHI/PM19/Y10 Meng Suan Road Male Juvenile 03/03/2010 
SG/EHI/PM20/Y10 Meng Suan Road Male Juvenile 03/03/2010 
SG/EHI/PM21/Y10 Meng Suan Road Female Juvenile 09/03/2010 
SG/EHI/PM22/Y10 Jalan Asas Male Juvenile 09/03/2010 
SG/EHI/PM23/Y10 Windsor Park Male Juvenile 10/03/2010 
SG/EHI/PM24/Y10 Windsor Park Male Adult 10/03/2010 
SG/EHI/PM25/Y10 Windsor Park Male Adult 10/03/2010 
SG/EHI/PM26/Y10 Mayfair Park Male Adult 15/03/2010 
SG/EHI/PM27/Y10 Rifle Range Road Male Adult 17/03/2010 
SG/EHI/PM28/Y10 Bukit Gombak Rise Male Adult 05/04/2010 
SG/EHI/PM29/Y10 Andrews Crescent Male Adult 09/04/2010 
SG/EHI/PM30/Y10 Changi Coast Road, NSRCC Male Juvenile 12/04/2010 
SG/EHI/PM31/Y10 Pulau Ubin Male Adult 16/04/2010 
SG/EHI/PM32/Y10 Pulau Ubin Male Juvenile 16/04/2010 
SG/EHI/PM33/Y10 Chestnut Road Male Juvenile 07/05/2010 
SG/EHI/PM34/Y10 Chestnut Road Male Juvenile 21/05/2010 
SG/EHI/PM35/Y10 Pulau Ubin Male Adult 24/05/2010 
SG/EHI/PM36/Y10 Pulau Ubin Male Adult 24/05/2010 
SG/EHI/PM37/Y10 Windsor Park Male Adult 24/08/2010 
SG/EHI/PM38/Y10 Linden Drive, Bukit Timah Male Adult 22/10/2010 
SG/EHI/PM39/Y10 Sim Road Male Adult 26/10/2010 
SG/EHI/PM40/Y10 Sim Road Male Adult 26/10/2010 
SG/EHI/PM41/Y10 Sime Road Male Adult 12/11/2010 
SG/EHI/PM42/Y10 Sime Road Male Adult 12/11/2010 
SG/EHI/PM43/Y10 Sime Road Female Adult 12/11/2010 
SG/EHI/PM44/Y10 Pulau Ubin Female Adult 19/11/2010 
SG/EHI/PM45/Y11 Rifle Range Road Male Adult 09/02/2011 
SG/EHI/PM46/Y11 Mount Pleasant Drive Male Juvenile 11/02/2011 
SG/EHI/PM47/Y11 Turf Club Road Female Adult 24/02/2011 
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Appendix C continued 
Code Location Gender Age Date collected 
SG/EHI/PM48/Y11 Chestnut Avenue Female Juvenile 16/03/2011 
SG/EHI/PM49/Y11 Chestnut Avenue Female Adult 01/04/2011 
SG/EHI/PM50/Y11 Singapore Island Country Club Male Adult 08/04/2011 
SG/EHI/PM51/Y11 West Lake Avenue Female Adult 08/04/2011 
SG/EHI/PM52/Y11 Rifle Range Road Male Adult 11/04/2011 
SG/EHI/PM53/Y11 Island Club Road Male Adult 11/04/2011 
SG/EHI/PM54/Y11 Island Club Road Male Adult 15/04/2011 
SG/EHI/PM55/Y11 Island Club Road Male Juvenile 15/04/2011 
SG/EHI/PM56/Y11 Island Club Road Male Adult 15/04/2011 
SG/EHI/PM57/Y11 Chestnut Avenue Female Adult 20/04/2011 
SG/EHI/PM58/Y11 Tanjong Pagar Community Club Male Adult 20/04/2011 
SG/EHI/PM59/Y11 Rifle Range Road Female Juvenile 20/04/2011 
SG/EHI/PM60/Y11 Chestnut Avenue Female Adult 26/04/2011 
SG/EHI/PM61/Y11 Chestnut Avenue Female Juvenile 26/04/2011 
SG/EHI/PM62/Y11 Chestnut Avenue Male Adult 26/04/2011 
SG/EHI/PM63/Y11 Chestnut Avenue Male Adult 26/04/2011 
SG/EHI/PM64/Y11 Chestnut Avenue Male Adult 26/04/2011 


















Appendix D: Details of wild long-tailed macaques and results of the species-
specific nested PCR assay. Macaques highlighted were tested negative for malaria 
parasites. Macques SG/EHI/WM1/Y07 to SG/EHI/WM86/Y11 were sampled from 
the restricted-access forest located in the northwestern Singapore, while 
SG/EHI/WM87/Y11 to SG/EHI/WM93/Y11 were from a military offshore island. 
 





SG/EHI/WM01/Y07 Male Adult 01/11/2007 + Pk, Pfi 
SG/EHI/WM02/Y07 Male Adult 01/11/2007 + Pk, Pcy 
SG/EHI/WM03/Y09 Male Juvenile 31/03/2009 + Pk 
SG/EHI/WM04/Y09 Male Adult 01/04/2009 + Pk 
SG/EHI/WM05/Y09 Male Adult 06/04/2009 + Pk, Pcy, Pfi 
SG/EHI/WM06/Y09 Male Juvenile 08/04/2009 + Pcy 
SG/EHI/WM07/Y09 Male Juvenile 08/04/2009 + Pcy 
SG/EHI/WM08/Y09 Female Juvenile 08/04/2009 - - 
SG/EHI/WM09/Y09 Male Juvenile 08/04/2009 + Pcy 
SG/EHI/WM10/Y09 Male Juvenile 08/04/2009 - - 
SG/EHI/WM11/Y09 Male Juvenile 08/04/2009 + Pk 
SG/EHI/WM12/Y09 Male Adult 14/04/2009 + Pk, Pcy 
SG/EHI/WM13/Y09 Male Juvenile 27/04/2009 + Pcy 
SG/EHI/WM14/Y09 Female Juvenile 27/04/2009 + Pk, Pcy 
SG/EHI/WM15/Y09 Male Juvenile 27/04/2009 + Pk, Pfi, Pct 
SG/EHI/WM16/Y09 Female Adult 07/05/2009 + Pk, Pcy 
SG/EHI/WM17/Y09 Female Juvenile 25/06/2009 + Pk 
SG/EHI/WM18/Y09 Female Juvenile 09/07/2009 + Pcy, Pfi 
SG/EHI/WM19/Y09 Female Juvenile 09/07/2009 + Pk, Pcy, Pfi 
SG/EHI/WM20/Y09 Female Adult 07/08/2009 + Pk 
SG/EHI/WM21/Y09 Female Juvenile 14/08/2009 + Pcy 
SG/EHI/WM22/Y09 Male Adult 18/08/2009 - - 
SG/EHI/WM23/Y09 Female Adult 01/09/2009 + Pcy 
SG/EHI/WM24/Y09 Female Juvenile 09/09/2009 + Pk 
SG/EHI/WM25/Y09 Male Adult 15/09/2009 + Pcy 
SG/EHI/WM26/Y09 Male Adult 25/09/2009 + Pk 
SG/EHI/WM27/Y09 Male Adult 02/10/2009 - - 
SG/EHI/WM28/Y09 Female Adult 06/10/2009 - - 
SG/EHI/WM29/Y09 Male Adult 13/10/2009 + Pk, Pcy 
SG/EHI/WM30/Y09 Male Adult 16/10/2009 + Pcy 
SG/EHI/WM31/Y09 Female Adult 20/10/2009 + Pk, Pcy 
SG/EHI/WM32/Y09 Male Adult 05/11/2009 + Pk, Pcy, Pfi 
SG/EHI/WM33/Y09 Male Adult 05/11/2009 + Pk, Pcy 
SG/EHI/WM34/Y09 Male Juvenile 05/11/2009 + Pcy 
SG/EHI/WM35/Y09 Female Juvenile 12/11/2009 + Pk 
SG/EHI/WM36/Y09 Male Adult 25/11/2009 + Pcy 
SG/EHI/WM37/Y09 Male Adult 04/12/2009 + Pcy, Pfi 
SG/EHI/WM38/Y09 Female Adult 22/12/2009 - - 
SG/EHI/WM39/Y09 Male Adult 22/12/2009 + Pk, Pcy, Pfi 
SG/EHI/WM40/Y10 Female Adult 06/01/2010 - - 
SG/EHI/WM41/Y10 Male Adult 06/01/2010 + Pcy 
SG/EHI/WM42/Y10 Male Adult 22/01/2010 + Pcy 
SG/EHI/WM43/Y10 Male Adult 27/01/2010 - - 
SG/EHI/WM44/Y10 Female Adult 11/02/2010 + Pcy, Pfi 
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Appendix D continued 





SG/EHI/WM45/Y10 Male Juvenile    12/02/2010 + Pk, Pcy 
SG/EHI/WM46/Y10 Male Adult 12/02/2010 + Pcy 
SG/EHI/WM47/Y10 Male Adult 23/02/2010 + Pcy 
SG/EHI/WM48/Y10 Male Juvenile 23/02/2010 + Pk 
SG/EHI/WM49/Y10 Female Adult 23/02/2010 + Pk 
SG/EHI/WM50/Y10 Female Adult 16/11/2010 + Pk 
SG/EHI/WM51/Y10 Male Adult 19/11/2010 + Pk, Pcy 
SG/EHI/WM52/Y10 Male Adult 23/11/2010 + Pk 
SG/EHI/WM53/Y10 Male Juvenile 23/11/2010 - - 
SG/EHI/WM54/Y10 Female Adult 23/11/2010 + Pk 
SG/EHI/WM55/Y10 Male Juvenile 25/11/2010 + Pcy 
SG/EHI/WM56/Y10 Female Adult 29/11/2010 + Pk, Pfi 
SG/EHI/WM57/Y10 Female Adult 29/11/2010 + Pk, Pcy 
SG/EHI/WM58/Y09 Male Adult 03/12/2010 - - 
SG/EHI/WM59/Y10 Male Adult 08/12/2010 + Pk, Pct 
SG/EHI/WM60/Y10 Female Adult 08/12/2010 - - 
SG/EHI/WM61/Y10 Female Adult 10/12/2010 - - 
SG/EHI/WM62/Y10 Male Adult 14/12/2010 - - 
SG/EHI/WM63/Y10 Male Adult 14/12/2010 + Pk 
SG/EHI/WM64/Y10 Too small for blood collection 
SG/EHI/WM65/Y10 Female Adult 16/12/2010 + Pk, Pfi 
SG/EHI/WM66/Y10 Female Adult 16/12/2010 + Pk, Pcy 
SG/EHI/WM67/Y10 Female Adult 20/12/2010 - - 
SG/EHI/WM68/Y10 Male Adult 22/12/2010 + Pk 
SG/EHI/WM69/Y10 Male Juvenile 22/12/2010 + Pk 
SG/EHI/WM70/Y10 Female Adult 22/12/2010 + Pk, Pcy 
SG/EHI/WM71/Y10 Female Adult 27/12/2010 + Pcy 
SG/EHI/WM72/Y10 Female Adult 30/12/2010 - - 
SG/EHI/WM73/Y10 Female Adult 30/12/2010 + Pk, Pcy 
SG/EHI/WM74/Y11 Female Juvenile 04/01/2011 + Pk 
SG/EHI/WM75/Y11 Male Juvenile 04/01/2011 + Pcy 
SG/EHI/WM76/Y11 Male Adult 07/01/2011 + Pk 
SG/EHI/WM77/Y11 Female Juvenile 18/01/2011 - - 
SG/EHI/WM78/Y11 Female Adult 28/01/2011 - - 
SG/EHI/WM79/Y11 Female Adult 03/03/2011 + Pcy 
SG/EHI/WM80/Y11 Male Adult 10/03/2011 + Pk 
SG/EHI/WM81/Y11 Female Juvenile 17/03/2011 + Pk, Pcy 
SG/EHI/WM82/Y11 Male Adult 25/03/2011 - - 
SG/EHI/WM83/Y11 Male Juvenile 29/03/2011 + Pk 
SG/EHI/WM84/Y11 Female Juvenile 01/04/2011 + Pk, Pcy 
SG/EHI/WM85/Y11 Male Juvenile 15/04/2011 - - 
SG/EHI/WM86/Y11 Male Juvenile 26/04/2011 - - 
SG/EHI/WM87/Y11 Male Adult 20/05/2011 - - 
SG/EHI/WM88/Y11 Male Adult 20/05/2011 - - 
SG/EHI/WM89/Y11 Male Adult 20/05/2011 - - 
SG/EHI/WM90/Y11 Male Adult 20/05/2011 - - 
SG/EHI/WM91/Y11 Male Adult 20/05/2011 + Pk, Pin 
SG/EHI/WM92/Y11 Male Adult 20/05/2011 - - 
SG/EHI/WM93/Y111 Female Adult 20/05/2011 - - 
Plasmodium coatneyi, P. cynomolgi, P. fieldi, P. inui and P. knowlesi were denoted by Pct, 
Pcy, Pfi, Pin and Pk, respectively. 
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Appendix E: DNA sequences of the csp genes (with GenBank accession number) 
P. coatneyi, CDC (JQ219880) 
 





P. inui, CDC (JQ219882) 
 
 




SG/EHI/H2/Y07-12 (P. knowlesi; JQ219894) 
 
 




SG/EHI/H24/Y08-10 (P. knowlesi; JQ219896) 
 





SG/EHI/H1-im/Y09 -25 (P. knowlesi; JQ219884) 
 
 





SG/EHI/H1-im/Y09 -95 (P. knowlesi; JQ219886) 
 




SG/EHI/H2-im/Y09 -3 (P. knowlesi; JQ219888) 
 





SG/EHI/H2-im/Y09 -11 (P. knowlesi; JQ219890) 
 




SG/EHI/H2-im/Y09 -18 (P. knowlesi; JQ219892) 
 




SG/EHI/WM01/Y07-23 (P. fieldi; JQ219931) 
 




SG/EHI/WM02/Y07-39 (P. knowlesi; JQ219899) 
 




SG/EHI/WM04/Y09-8 (P. knowlesi; JQ219900) 
 




SG/EHI/WM04/Y09-12 (P. knowlesi; JQ219902) 
 




SG/EHI/WM04/Y09-14 (P. knowlesi; JQ219904) 
 





SG/EHI/WM05/Y09-70 (P. knowlesi; JQ219906) 
 




SG/EHI/WM05/Y09-65 (P. cynomolgi; JQ219923) 
 




SG/EHI/WM11/Y09-74 (P. knowlesi; JQ219908) 
 




SG/EHI/WM15/Y09-163 (P. fieldi; JQ219933) 
 




SG/EHI/WM16/Y09-2 (P. cynomolgi; JQ219924) 
 




SG/EHI/WM17/Y09-4 (P. knowlesi; JQ219911) 
 




SG/EHI/WM18/Y09-24 (P. cynomolgi; JQ219926) 
 




SG/EHI/WM26/Y09-1 (P. knowlesi; JQ219913) 
 




SG/EHI/WM26/Y09-47(P. knowlesi; JQ219915) 
 




SG/EHI/WM26/Y09-98 (P. knowlesi; JQ219917) 
 




SG/EHI/WM33/Y09-39 (P. knowlesi; JQ219919) 
 




SG/EHI/WM35/Y09-38 (P. knowlesi; JQ219920) 
 




SG/EHI/WM42/Y10-1 (P. cynomogi; JQ219928) 
 




SG/EHI/WM44/Y10-30 (P. cynomogi; JQ219930) 
 




SG/EHI/WM91/Y11-61 (P.inui; JQ219936) 
 
SG/EHI/WM91/Y11-73 (P.inui; JQ219937) 
 
 169 
 
 
